Thursday, June 26, 2008

DRUGS with Trade name--C

Caffeine

Trade Name(s): Caffedrine, NoDoz, Vivarin, Quick Pep

Chemically Related To: Xanthine

Pregnancy Category: B

Medical Category: Cerebral stimulant, analgesia adjunct, respiratory stimulant

Accepted Indications: Fatigue, drowsiness, vascular headache

Mechanism of Action: Phosphodiesterase inhibitor; CNS stimulant

Absorption/Distribution: Excellent absorption, rapid distribution

Half life: 3–{endash}7 hours

PO: 50–{endash}75 minutes

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: Extended release capsules: 200-250 mg every 3–{endash}4 h, not to exceed 1 g/d; tablets: 100–{endash}200 mg every 3–{endash}4 h, not to exceed 1 g/d

Elderly Dosage: Same as adult dose

Child Dosage: Not recommended

Infant Dosage: For sleep apnea, 10 mg/kg as a loading dose then 2.5 mg/d

Dosage Forms: Extended-release capsules: 200 mg and 250 mg; tablets: 75 mg, 100 mg, 150 mg, and 200 mg

By System: CNS

Precautions: Check with physician if drowsiness occurs

Frequent Side Effects: CNS stimulation, nausea/vomiting

Overdosage: GI pain, delirium, insomnia, dehydration, fever

Antidotal Therapy: May include short-acting barbiturates, gastric emesis/lavage, diazepam

Disease States: Anxiety disorders, heart and liver problems, hypertension, insomnia, peptic ulcer

Other Drugs: Theophylline, beta-adrenergic agonists, MAO inhibitors, lithium, oral contraceptives, adenosine

Lab Tests: Blood glucose, serum urate measurements, catecholamines, 5-hydroxyindoleacetic acid, vanillylmandelic acid

Administrative Notes: Caffeine tablets may be made into a suspension when used in neonatal apnea

Caffeine/Ergotamine Tartrate

Trade Name(s): Cafergot, Cafermine, Cafetrate, Ercaf, Ergo-Caff, Gotamine, Migergot, Wigraine

Pregnancy Category: C

Medical Category: Antimigraine

Accepted Indications: Migraine headache

Adult Dosage: Tablets: 2 tablets initially, followed by 1 tablet every 0.5 h, not to exceed 6 tablets/episode or 10 tablets/w; suppositories: maximal dose of 2 suppositories/episode or 5 suppositories/w

Child Dosage: Not recommended

Dosage Forms: Tablets: 100 mg/1 mg; suppositories: 100 mg/2 mg

Calcitriol

Trade Name(s): Calcijex, Rocaltrol

Chemically Related To: Vitamin D

Pregnancy Category: C

Medical Category: Antihypocalcemic, nutritional supplement

Accepted Indications: Chronic hypocalcemia, hypophosphatemia, rickets, vitamin D deficiency

Mechanism of Action: Binds to a specific receptor in the GI tract cell cytoplasm that results in increased absorption of calcium from the intestine

Absorption/Distribution: Readily absorbed

Half life: 3–{endash}6 h

PO: 3–{endash}6 h

Elimination: Biliary/renal

Research Notes: Stored mainly in the liver

Adult Dosage: Capsules: 0.25m{mu}g/d initially, dosage increased to 2–{endash}3 m{mu}g/d; injection: 0.5 m{mu}g/kg 3 times/w initially, dosage then increased

Child Dosage: Capsules: 0.25 m{mu}g/d initially, dosage then increased; injection: not established

Infant Dosage: Not established

Dosage Forms: Capsules 0.25 m{mu}g and 0.5 m{mu}g, injection 1 m{mu} g/mL and 2 m{mu}/mL

By System: Vitamin replacement

Precautions: Megadoses not recommended

Contraindications: Hypercalcemia, hypervitaminosis D

Overdosage: Constipation, dry mouth, headache, increased thirst, loss of appetite, metallic taste, nausea or vomiting, weakness, bone pain, muscle pain

Antidotal Therapy: May include withdrawal of the vitamin, low-calcium diet, generous fluid intake, prednisone

Disease States: Arteriosclerosis, cardiac function impairment, hyperphosphatemia, sarcoidosis

Other Drugs: Antacids, anticonvulsants, barbiturates, calcitonin, thiazide diuretics, digitalis glycosides, phosphorus–{endash}containing preparations

Lab Tests: Alkaline phosphatase, serum cholesterol, magnesium, calcium, and phosphate concentrations

Administrative Notes: To be most effective, give in divided doses

Calcium Acetate

Trade Name(s): PhosLo

Chemically Related To: Ion element

Pregnancy Category: C

Medical Category: Antihyperphosphatemic

Accepted Indications: Hyperphosphatemia

Mechanism of Action: Combines with dietary phosphate to form insoluble phosphorus, which is excreted in feces

Absorption/Distribution: 40% systemically absorbed

Elimination: Fecal

Research Notes: Does not promote aluminum absorption

Adult Dosage: 2 tablets t.i.d. with meals up to 3–{endash}4 tablets/meal

Dosage Forms: Tablets: 667 mg (169 mg of calcium)

By System: Serum ion levels

Warnings: Follow diet

Precautions: Avoid antacids

Frequent Side Effects: Hypercalcemia

Occasional Side Effects: Nausea

Rare Side Effects: Pruritus

Overdosage: Hypercalcemia

Antidotal Therapy: May include acute hemodialysis

Other Drugs: Tetracycline, digitalis

Administrative Notes: Take with meals; reduce dietary intake of phosphate

Calcium Carbonate

Trade Name(s): Alka-Mints, Calcium 600, Dicarbosil, Gencalc, Titralac, Tums

Chemically Related To: Unique compound

Pregnancy Category: C

Medical Category: Antihypocalcemic, nutritional supplement, antihyperphosphatemic, antacid

Accepted Indications: Hypocalcemia, calcium deficiency, hyperacidity, hyperphosphatemia, GI hyperacidity

Mechanism of Action: Elevates gastric pH

Absorption/Distribution: 33% absorbed in the small intestine; moderate protein binding

Elimination: Fecal, renal

Research Notes: Contains equivalent of 400 mg of calcium ion/g

Adult Dosage: 1.5 g once daily to t.i.d.

Elderly Dosage: May need increased dose

Dosage Forms: Capsules: 1.5 g; oral suspension 1 g/5 mL and 1.25 g/5 mL; tablets: 650 g, 667 g, 1.25 g, and 1.5 g; chewable tablets: 420 g, 500 g, 550 g, 625 g, 750 g, l.25 g, and 1.5 g

By System: GI tract

Warnings: Avoid excessive intake of alcohol, tobacco, or caffeine

Precautions: Monitor serum calcium; take with a full glass of water

Rare Side Effects: Drowsiness, nausea/vomiting, weakness, renal calculi

Contraindications: Severe renal disease, renal calculi (calcium), hypercalcemia, hypercalciuria

Overdosage: Constipation, dry mouth, headache, irritability, depression, weakness, confusion

Antidotal Therapy: May include hydration with IV 0.9% sodium chloride injection; force diuresis with furosemide; EKG monitoring; beta-adrenergic blockers

Disease States: Achlorhydria, diarrhea, dehydration, GI malabsorption

Other Drugs: Tetracyclines, cellulose sodium phosphate, digitalis, gallium nitrate, magnesium sulfate, phenytoin, ciprofloxacin

Lab Tests: Serum phosphate

Administrative Notes: If taken as a phosphate binder in renal dialysis, do not take with glass of water; do not take with milk and foods high in vitamin D

Calcium Iodide

Trade Name(s): Not available as single agent

Medical Category: Expectorant

Accepted Indications: Cough

Calcium Iodide/Codeine Phosphate

Trade Name(s): Calcidrine

Scheduled Class: V

Pregnancy Category: D

Medical Category: Antitussive, expectorant

Accepted Indications: Cough

Adult Dosage: Syrup: 5–{endash}10 mL every 4h

Child Dosage: Syrup: 2–{endash}6 y: 2.5 mL; 6–{endash}10 y: 2.5–{endash}5 mL every 4 h

Dosage Forms: Syrup: 152 mg/8.4 mg

By System: Respiratory

Warnings: Use during pregnancy could result in fetal goiter and respiratory problems in neonates

Precautions: Thyroid function tests

Frequent Side Effects: Metallic taste, acne-like lesions, irritation of mucous membranes, GI problems

Rare Side Effects: Severe and sometimes fatal skin eruptions, thyroid function abnormalities

Contraindications: Pregnancy, Iodism

Overdosage: Respiratory and CNS depression, pinpoint pupils, coma, decreased blood pressure, decreased body temperature, GI irritation, angioedema with laryngeal swelling, shock

Antidotal Therapy: May include establishment of patent airway, gastric lavage, treatment for shock, supportive measures, naloxone

Lab Tests: Thyroid function tests, protein-bound iodine, benzidine testing

Administrative Notes: Keep tightly closed and protected from light

Captopril

Trade Name(s): Capoten

Chemically Related To: Enalapril

Pregnancy Category: C in 1st trimester; D in 2nd and 3rd trimesters

Medical Category: Antihypertensive

Accepted Indications: Hypertension, CHF, proteinuria in diabetes

Mechanism of Action: Inhibits ACE and decreases peripheral vascular resistance

Absorption/Distribution: 75% from GI tract

Half life: <>

PO: 60–{endash}90 min

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: 6.25–{endash}450 mg/d

Elderly Dosage: Decrease dose

Child Dosage: Dosage not established

Infant Dosage: May cause neonatal hypertension

Dosage Forms: Tablets: 12.5 mg, 25 mg, 50 mg, and 100 mg

By System: Vasodilator

Warnings: Caution in use with antiarrhythmic medication

Precautions: May cause dizziness

Frequent Side Effects: Cough, headache, nausea, dizziness

Occasional Side Effects: Rash, joint pain, loss of taste, hypotension

Rare Side Effects: Chest pain, angioedema, agranulocytosis, hyperkalemia

Antidotal Therapy: May include hemodialysis

Disease States: Renal impairment, bone marrow depression

Nutrition: Food delays absorption

Other Drugs: Alcohol, diuretics, estrogens, NSAIDs

Lab Tests: BUN, hemoglobin, hematocrit

Captopril/Hydrochlorothiazide

Trade Name(s): Capozide 25/15, 25/25, 50/15, 50/25

Pregnancy Category: C

Medical Category: Antihypertensive

Accepted Indications: Hypertension

Dosage Forms: Tablets: 25 mg/15 mg, 25 mg/25 mg, 50 mg/15 mg, and 50 mg/25 mg

Caramiphen Edisylate/Phenylpropanolamine Hydrochloride

Trade Name(s): De-Tuss, Ordrine AT, Tuss-Allergine, Tuss Vernade

Pregnancy Category: C

Medical Category: Decongestant-antitussive

Accepted Indications: Cough and cold symptoms

Dosage Forms: Capsules: 40 mg/75 mg; sustained-action liquid: 6.7 mg/12.5 mg

Caramiphen/Phenylpropanolamine

Trade Name(s): Tuss-Ornade Spansule

Chemically Related To: Phenylethylamine/noscapine

Medical Category: Decongestant-antitussive

Accepted Indications: Cough and cold symptoms

Mechanism of Action: Helps to restrict blood vessels to alleviate nasal congestion. Also helps to loosen mucus in the respiratory tract

Absorption/Distribution: Readily absorbed

Elimination: Hepatic

Research Notes: Renal

Adult Dosage: 1 capsule q 12 h

Elderly Dosage: See adult

Child Dosage: Not available

Dosage Forms: Capsules

By System: Respiratory

Precautions: Postpartum women may be at greater risk than rest of population of developing psychiatric disorders with the use of phenylpropanolamine

Occasional Side Effects: Dryness of mouth, insomnia

Rare Side Effects: Headache, increased blood pressure, painful urination

Overdosage: Abdominal pain, fast heartbeat, headache, nausea

Disease States: Cardiovascular disease, diabetes, hypertension, thyroid disease

Other Drugs: Antidepressants, antihypertensives, beta-adrenergic blocking agents, CNS stimulants, MAO inhibitors, rauwolfia alkaloids

Administrative Notes: Caution when taking phenylpropanolamine–{endash}containing appetite suppressants; possible insomnia

Carbachol

Trade Name(s): Isopto Carbachol, Miostat

Chemically Related To: Acetylcholine

Pregnancy Category: Not documented

Medical Category: Antiglaucoma agent, miotic

Accepted Indications: Open-angle glaucoma, miotic

Mechanism of Action: Stimulates cholinergic receptors

Half life: 2–{endash}12 h

Peak activity: Intraocular solution 2–{endash}5 min; topical solution within 4 h

Research Notes: Intraocular duration of miotic action 24 h; topical duration of action 4–{endash}8 h

Adult Dosage: 1 drop of a 0.75% to 3% solution t.i.d.

Elderly Dosage: Same as adult dose

Child Dosage: Same as adult dose

Infant Dosage: Same as adult dose

Dosage Forms: Intraocular solution 0.1%, ophthalmic solution 0.75%, 1.5%, 2.25%, and 3%

By System: Ophthalmic parasympathomimetic

Warnings: Discard unused portion

Precautions: Caution if blurred vision occurs

Frequent Side Effects: Blurred vision, eye pain

Occasional Side Effects: Headache, ocular irritation, eyelid twitching

Overdosage: Systemic absorption, diarrhea, stomach cramps, flushing of face, increased sweating, excessive salivation

Antidotal Therapy: May include atropine sulfate injection

Disease States: Bronchial asthma, acute cardiac failure, corneal abrasion, GI spasm, iritis, urinary tract obstruction

Other Drugs: Belladonna alkaloids (ophthalmic), cyclopentolate, ophthalmic flurbiprofen

Administrative Notes: Tolerance possible with prolonged use

Carbamazepine

Trade Name(s): Tegretol

Chemically Related To: Tricyclic antidepressants

Pregnancy Category: C

Medical Category: Anticonvulsant, antineuralgic

Accepted Indications: Epilepsy, neuralgia

Unaccepted Indications: Epileptic atonic seizures

Mechanism of Action: Blocks action of neurotransmitters

Absorption/Distribution: Slow but complete absorption from GI tract

Half life: 25–{endash}65 h

PO: 4.5 h

Metabolism: Hepatic

Elimination: Renal, fecal

Research Notes: Onset of action in treatment of mania: 7–{endash}10 d

Adult Dosage: 200 mg b.i.d. up to 1.6 g/d

Elderly Dosage: Because of decreased kidney function in elderly patients, a decrease in dosage recommended; confusion, agitation, and heart block possible

Child Dosage: 250–{endash}350 mg up to 6 y; 400–{endash}800 mg up to 12 y

Infant Dosage: Same as child dose

Dosage Forms: Oral suspension 100 mg/5 mL, tablets 200 mg, chewable tablets 100 mg

By System: CNS

Warnings: Possible anticholinergic side effects

Precautions: Cross-sensitivity with tricyclic antidepressants

Frequent Side Effects: Blurred vision

Occasional Side Effects: Lightheadedness, gastric upset, confusion, unsteadiness

Rare Side Effects: Systemic lupus erythematosus, changes in behavior, blood dyscrasias

Contraindications: Cardiac disorders, such as heart block; atonic seizures; blood disorders; bone marrow depression

Overdosage: Tachycardia, hypotension, hypertension, breathing difficulties, shock, seizures

Antidotal Therapy: May include gastric lavage, activated charcoal, diuresis

Disease States: CNS or heart disorders, kidney problems

Nutrition: Take with food to reduce GI distress

Other Drugs: Anticonvulsants, tricyclic antidepressants, anticoagulants, erythromycins, MAO inhibitors

Lab Tests: Metyrapone

Administrative Notes: Protect drug from moisture; store in a dry place

Carbenicillin Indanyl Sodium

Trade Name(s): Geocillin

Chemically Related To: Penicillin

Pregnancy Category: B

Medical Category: Antibacterial, antipseudomonal penicillin

Accepted Indications: Urinary tract infections, prostatitis

Mechanism of Action: Bactericidal, cell wall synthesis inhibited

Absorption/Distribution: 30%–{endash}50% absorbed; moderate protein binding; oral carbenicillin at therapeutic concentrations only in the urine

Half life: 1–{endash}1.5 h

PO: 1–{endash}3 h

Elimination: 60%–{endash}90% excreted unchanged renal

Research Notes: In severely impaired renal function, therapeutic urine concentrations of carbenicillin not achieved

Adult Dosage: Oral: 382–{endash}764 mg q.i.d.

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Tablets: 382 mg

Warnings: Bleeding time determinations suggested before and during prolonged therapy in patients with renal function impairment; in elderly, with decrease in renal function, dosage adjustment suggested

Frequent Side Effects: GI reactions, oral candidiasis

Rare Side Effects: Allergic reactions, especially anaphylaxis, serum sickness–{endash}like or hematologic reactions, rash, platelet dysfunction, interstitial nephritis

Disease States: History of bleeding disorders, GI disease, infectious mononucleosis, renal function impairment

Other Drugs: Coumarin anticoagulants, NSAIDs, captopril, potassium–{endash}sparing diuretics, potassium supplements, sulfinpyrazone, platelet aggregation inhibitors

Lab Tests: Bleeding time; antiglobulin test; alanine aminotransferase aspartate aminotransferase levels; hypernatremia; hypokalemia

Administrative Notes: Oral absorption increased by food; for severe diarrhea, check with physician before taking any antidiarrheals

Carbetapentane Tannate

Trade Name(s): Not available as single agent

Chemically Related To: Antihistamines

Pregnancy Category: C

Medical Category: Antitussive

Accepted Indications: Cough

Infant Dosage: Avoid in newborns

Carbidopa

Trade Name(s): Not available as a single agent

Chemically Related To: Dopamine

Pregnancy Category: C

Medical Category: Decarboxylase inhibitor

Accepted Indications: None. Has no effect when given alone; indicated only for use with levodopa.

Mechanism of Action: Inhibits peripheral decarboxylation of levodopa

Absorption/Distribution: Complete and rapid absorption; widely distributed

Half life: 1–{endash}2 h

Metabolism: Little metabolism, actually slows metabolism of levodopa in GI tract

Elimination: Renal

Research Notes: Used primarily in combination with levodopa, as it allows less levodopa to be used

Other Drugs: Tricyclic antidepressants

Carbidopa

Trade Name(s): Not available as a single agent

Chemically Related To: Dopamine

Pregnancy Category: C

Medical Category: Decarboxylase inhibitor

Accepted Indications: None. Has no effect when given alone; indicated only for use with levodopa.

Mechanism of Action: Inhibits peripheral decarboxylation of levodopa

Absorption/Distribution: Complete and rapid absorption; widely distributed

Half life: 1–{endash}2 h

Metabolism: Little metabolism, actually slows metabolism of levodopa in GI tract

Elimination: Renal

Research Notes: Used primarily in combination with levodopa, as it allows less levodopa to be used

Other Drugs: Tricyclic antidepressants

Carbidopa/Levodopa

Trade Name(s): Sinemet, Sinemet CR

Pregnancy Category: C

Medical Category: Antidyskinetic

Accepted Indications: Parkinsonism

Mechanism of Action: Carbidopa inhibits peripheral decarboxylation of levodopa, thus slowing its conversion peripherally and increasing its availability centrally

Absorption/Distribution: Complete and rapid absorption; widely distributed

Half life: 1–{endash}2 h

Peak activity: Tablets: 0.7 h; extended-release tablets: 2.4 h

Elimination: Renal

Adult Dosage: 10 mg/100 mg t.i.d. or 25 mg/100 mg t.i.d. initially, then increase dosage

Elderly Dosage: Lower dose may be required

Child Dosage: Safety and efficacy not established

Infant Dosage: Safety and efficacy not established

Dosage Forms: Tablets: 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg; extended-release tablets: 25 mg/100 mg and 50 mg/200 mg

By System: CNS

Warnings: May darken urine or perspiration

Precautions: Caution if surgery required

Frequent Side Effects: Mental depression, uncontrolled movement, anxiety, nervousness

Occasional Side Effects: Difficulty in urination, orthostatic hypotension, anorexia, constipation, headache, insomnia, irregular heartbeat, nausea, vomiting, blurred vision, diarrhea, dry mouth, flushing, muscle twitching, unusual tiredness, nightmares, dark urine

Rare Side Effects: Duodenal ulcer, hemolytic anemia, hypertension

Antidotal Therapy: No specific antidote; may include gastric lavage, antiarrhythmics

Disease States: Asthma, emphysema, myocardial infarction, heart disease, psychotic states, glaucoma

Other Drugs: Anticonvulsants, phenothiazines, cocaine, MAO inhibitors, haloperidol, hydrocarbon anesthetics, selegiline

Administrative Notes: Take food after medication. Store in a light-resistant container.

Carbinoxamine Maleate

Trade Name(s): Not available as a single agent

Chemically Related To: Ethanolamine

Pregnancy Category: C

Medical Category: Antihistamine

Accepted Indications: Rhinitis, allergy symptoms

Mechanism of Action: Competes for H1 receptor site

Carbinoxamine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride

Trade Name(s): Carbodec-DM, Cardec-DM, Pseudo-Car DM, Rondamine-DM, Rondec-DM, Tussafed

Pregnancy Category: C

Medical Category: Antihistamine, antitussive

Accepted Indications: Coughs and colds

Adult Dosage: Syrup: 5 mL every 4–{endash}6 h

Child Dosage: 18 m–{endash}6 y: syrup, 2.5 mL; over 6 y: syrup, 5 mL every 4–{endash}6 h

Infant Dosage: 1–{endash}3 m: 0.25 mL drops; 3–{endash}6 m: 0.50 mL drops; 6–{endash}9 m: 0.75 mL drops; 9-18 m: 1 mL drops every 4–{endash}6 h

Dosage Forms: Oral solution: 2 mg/mL/4 mg/mL/25 mg/mL; syrup: 4 mg/5 mL 15 mg/5 mL 60 mg/5 mL

Carbinoxamine Maleate/Pseudoephedrine Hydrochloride

Trade Name(s): Carbiset-TR, Carbodec, Carbodec TR, Cardec-S, Rondec, Rondec Drops, Rondec-TR

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Coughs, colds, and allergies

Adult Dosage: Tablets: 1 tablet q.i.d.; extended-release tablets: 1 tablet b.i.d.; syrup: 5 mL q.i.d.

Child Dosage: 6–{endash}12 y, tablets: 1 tablet q.i.d.; syrup, 5 mL q.i.d. 18 m–{endash}6 y, syrup: 2.5 mL q.i.d.

Infant Dosage: Drops, 1–{endash}3 m: 0.25 mL q.i.d., 3–{endash}6 m: 0.5 mL q.i.d., 6–{endash}9 m: 0.75 mL q.i.d., 9–{endash}18 m: 1 mL q.i.d.

Dosage Forms: Syrup: 4 mg/60 mg; tablets 4 mg/60 mg; extended-release tablets: 8 mg/120 mg; drops: 2 mg/mL and 25 mg/mL

Carboplatin

Trade Name(s): Paraplatin, Paraplatin-AQ

Chemically Related To: Cisplatin

Pregnancy Category: D

Medical Category: Antineoplastic

Accepted Indications: Ovarian, lung, head and neck, and testicular carcinomas

Mechanism of Action: Inhibits DNA

Half life: Alpha 1.1–{endash}2 h; beta 2.6–{endash}5.9 h

Elimination: Renal

Research Notes: Not cell-cycle or phase specific

Adult Dosage: Ovarian carcinoma: initial IV 300 mg/m2 every 4 w for 6 cycles, in combination with IV 600 mg/m2 cyclophosphamide every 4 w for 6 cycles. If refractory to other chemotherapy, IV 360 mg/m2 once every 4 w

Elderly Dosage: Peripheral neurotoxicity and severity of myelotoxicity increased; may require lower doses

Child Dosage: Not established

Dosage Forms: Injection: 50 mg, 150 mg, and 450 mg

By System: Growing cells

Warnings: Avoid immunizations; be monitored by physician

Precautions: Caution if taking combination therapy; take medication even if GI distress occurs

Frequent Side Effects: Anemia, leukopenia, pain at injection site, nausea and vomiting, thrombocytopenia

Occasional Side Effects: Tingling in extremities, tinnitus, constipation, diarrhea, appetite or hair loss

Rare Side Effects: Blurred vision, stomatitis

Disease States: Bleeding, bone marrow depression, infection, kidney problems, ascites

Other Drugs: Bone marrow depressants, cisplatin, vaccines, ototoxic or nephrotoxic medications, live virus vaccines.

Lab Tests: BUN, bilirubin, calcium, magnesium, potassium and sodium serum concentrations, creatinine

Administrative Notes: Often given with cyclophosphamide in 6 cycles

Carisoprodol

Trade Name(s): Soma

Chemically Related To: Meprobamate

Abuse Potential: Increasing

Pregnancy Category: Not documented

Medical Category: Skeletal muscle relaxant

Accepted Indications: Skeletal muscle spasm

Mechanism of Action: Acts in CNS to depress activity and block interneuronal activity

Absorption/Distribution: Partially absorbed; distributed in all body tissues

Half life: 8 h

Peak activity: 4 h

PO: 4 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Psychological dependence and abuse reported rarely; withdrawal symptoms possible if drug is discontinued abruptly

Adult Dosage: 350 mg q.i.d.

Elderly Dosage: Same as adult dosage

Child Dosage: Under 5 y: not established; 5–{endash}12 y: 6.25 mg/kg q.i.d.

Infant Dosage: Not established

Dosage Forms: Tablets: 350 mg

By System: CNS

Precautions: Excreted in breast milk; causes sedation in breastfed infant

Frequent Side Effects: Drowsiness

Occasional Side Effects: Tachycardia, mental depression, angioedema, bronchospastic allergic reaction, fever, burning sensation in eyes, dizziness, trembling, GI irritation, hiccups, nausea

Rare Side Effects: Anemia, leukopenia, eosinophilia, erythema multiforme, blurred vision, clumsiness

Contraindications: Porphyria

Overdosage: Drowsiness, tachycardia, flushing, hypotension, coma

Antidotal Therapy: May include emesis or gastric lavage; supportive treatment; respiratory assistance, CNS stimulants, and pressor agents used cautiously, if necessary; hemodialysis; monitor urinary output

Disease States: Porphyria

Other Drugs: CNS depression–{endash}producing medications

Lab Tests: Urine

Administrative Notes: Avoid alcohol

Casanthranol

Trade Name(s): Black-Draught

Medical Category: Stimulant or contact laxative

Accepted Indications: Constipation, bowel evacuation

Mechanism of Action: Affects smooth intestinal musculature

Adult Dosage: Syrup: 30 mL/d maximum

Dosage Forms: Syrup: 30 mg/5 mL

Occasional Side Effects: Belching, cramping, diarrhea, nausea, rectal irritation

Rare Side Effects: Rash, electrolyte imbalance

Contraindications: CHF, diabetes, hypertension, appendicitis

Disease States: Intestinal obstruction, rectal bleeding

Nutrition: Do not drink milk

Other Drugs: H2 blockers, milk, potassium–{endash}sparing diuretics, potassium supplements, antacids

Lab Tests: PSP test

Cascara Sagrada

Trade Name(s): Generic only

Medical Category: Stimulant or contact laxative

Accepted Indications: Constipation, evacuation

Mechanism of Action: Affects smooth intestinal musculature

Adult Dosage: Tablets: 1 tablet/d maximum; oral solution: 5 mL/d, up to 15 mL/d

Elderly Dosage: Use with caution

Child Dosage: Tablets: not recommended; oral solution: over 2 y: 1–{endash}3 mL/d

Infant Dosage: Not recommended

Dosage Forms: Tablets: 150 mg; oral solution; 1 g/mL

Occasional Side Effects: Bloating, belching, rectal irritation, cramping, diarrhea, nausea

Rare Side Effects: Rash, electrolyte imbalance, urine discoloration

Contraindications: Diabetes, CHF, hypertension, appendicitis

Disease States: Intestinal obstruction, rectal bleeding

Other Drugs: H2 blockers, potassium–{endash}sparing diuretics, potassium supplements, antacids, milk

Lab Tests: PSP test

Cefaclor

Trade Name(s): Ceclor

Chemically Related To: Cephalosporins; second-generation cephalosporin

Pregnancy Category: B

Medical Category: Antibacterial, second-generation cephalosporin

Accepted Indications: Haemophilus influenzae infections, septicemia, bone and joint infections, gram-negative pneumonia, skin and soft tissue infections, bacterial urinary tract infections, amoxicillin-resistant otitis media and sinusitis

Unaccepted Indications: Enterococcal, listerial, clostridial, and methicillin-resistant staphylococcal infections

Mechanism of Action: Prevents formation of peptidoglycan chains; destroys bacterial cell wall integrity

Absorption/Distribution: Well absorbed in all body tissues

Peak activity: 1–{endash}3 h

PO: Widely distributed throughout soft tissues

Elimination: Renal

Adult Dosage: 500–{endash}1500 mg/d

Elderly Dosage: Do not exceed 1 g/d

Child Dosage: 60 mg/kg/d

Infant Dosage: Up to 40 mg/kg/d

Dosage Forms: Capsules: 250 mg and 500 mg; suspension: 125 mg/5 mL and 250 mg/5 mL

Warnings: Severe diarrhea

Frequent Side Effects: GI cramps, diarrhea

Occasional Side Effects: Stomach cramps, rash, allergy

Rare Side Effects: Thrombophlebitis, hepatitis, CNS disturbance

Contraindications: Allergy to compound

Disease States: Bleeding disorders, GI disease, hepatic or renal impairment

Other Drugs: Alcohol, anticoagulants, and heparin

Cefadroxil

Trade Name(s): Duricef

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, first-generation cephalosporin

Accepted Indications: Gram-positive bacteria, E. coli, Proteus mirabilis, and Klebsiella species

Unaccepted Indications: Staphylococcal, listerial, or clostridial infections

Mechanism of Action: Blocks materials necessary for building of bacterial cell wall

Absorption/Distribution: Well absorbed with food; widely distributed

Half life: 1.2–{endash}1.5 h

PO: 1.5–{endash}2 h

Metabolism: 10% metabolized

Elimination: Renal

Research Notes: Prolonged half-life reported in neonates

Adult Dosage: 500 mg b.i.d. up to 4 g/d; decrease dose with kidney problems

Elderly Dosage: Same as adult dose

Child Dosage: 15 mg/kg b.i.d.

Infant Dosage: Same as child dose

Dosage Forms: Capsules: 500 mg; tablets: 1 g; oral suspension: 125 mg/5 mL, 250 mg/5 mL and 500 mg/5 mL

Warnings: Possible cross-sensitivity with penicillins

Precautions: Do not take antidiarrheal preparations without consulting physician

Frequent Side Effects: Sores in mouth, diarrhea, nausea and vomiting

Occasional Side Effects: Bleeding and bruising, stomach cramps, fever

Rare Side Effects: Hypotension, kidney problems, hypersensitivity

Contraindications: Sensitivity to penicillins

Disease States: Hepatic or renal impairment, bleeding disorders, GI problems

Other Drugs: Anticoagulants, thrombolytics, probenecid, alcohol

Lab Tests: Urine and blood glucose, prothrombin time, Coombs' test

Administrative Notes: With food, increased drug blood level. Calibrated liquid-measuring device available.

Cefixime

Trade Name(s): Suprax

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, third-generation cephalosporin

Accepted Indications: Infections caused by Streptococcus pyogenes, Streptococcus pneumoniae, gram-negative bacteria

Unaccepted Indications: Infections caused by Pseudomonas aeruginosa, staphylococci

Mechanism of Action: Disturbs bacterial cell wall integrity

Absorption/Distribution: Almost 50% bioavailability; does not cross into CSF

Half life: 3–{endash}4 h

PO: 2.6 h

Metabolism: Not metabolized

Elimination: Renal

Research Notes: One of 2 third-generation cephalosporins

Adult Dosage: 200 mg b.i.d. to a limit of 400 mg/d

Elderly Dosage: Lower dose with kidney problems

Child Dosage: 4 mg/kg b.i.d. or 8 mg/kg once daily

Infant Dosage: Over 6 m: same as child dose

Dosage Forms: Oral suspension: 100 mg/5 mL; tablets: 200 mg and 400 mg

Warnings: Do not take antidiarrheal medications without consulting physician

Precautions: Do not stop medication until treatment course is ended

Frequent Side Effects: Diarrhea

Occasional Side Effects: GI disturbances, colitis, sore mouth and tongue

Rare Side Effects: Vaginitis

Contraindications: Allergic reactions to penicillins

Antidotal Therapy: No specific antidote; may include supportive treatment

Disease States: Renal function impairment, GI disease, bleeding disorders

Other Drugs: Anticoagulants, thrombolytic agents, alcohol

Lab Tests: Coombs' test, prothrombin time

Administrative Notes: Take with food to lessen GI distress. Reconstituted suspension retains potency for 14 d.

Cefmetazole Sodium

Trade Name(s): Zefazone

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Second-generation cephalosporin

Accepted Indications: Septicemia, bone and joint infections, gram-negative pneumonia, skin and soft tissue infections, urinary tract infections, Bacteroides fragilis infections, aspiration pneumonia, diabetic foot infections, intra-abdominal and pelvic infections, perioperative infection prophylaxis, gonorrhea, lower respiratory infections

Unaccepted Indications: Infections caused by Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermis or S. aureus, or enterococci

Mechanism of Action: Interferes with cell wall synthesis

Absorption/Distribution: Widely distributed throughout body

Half life: 0.8–{endash}1.8 h

IV: End of infusion

Metabolism: Not metabolized

Elimination: Renal

Adult Dosage: Antibacterial: IV, 2 g b.i.d. to q.i.d. for 5–{endash}14 d; gonorrhea: IM, 1 g as a single dose concurrent with 1 g of probenecid; perioperative prophylaxis: IV, 2 g 30–{endash}90 min before surgery or 1–{endash}2 g 30–{endash}90 min before surgery and repeat in 8 and 16 h

Elderly Dosage: Lower dosage may be required

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: For injection: 1 g and 2 g

Warnings: Adjust dose for renal impairment; comply with full course of therapy

Frequent Side Effects: GI reactions, oral candidiasis, vaginal candidiasis

Occasional Side Effects: Hypothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reaction, thrombophlebitis, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like syndrome, seizures

Antidotal Therapy: May include metronidazole, vancomycin for C. difficile infections

Compatibility of Solutions: Incompatible with heparin, aminoglycosides

Disease States: Bleeding disorders, GI disease, renal function impairment

Other Drugs: Alcohol, anticoagulants, probenecid, heparin, thrombolytic agents, platelet aggregation inhibitors

Lab Tests: Prothrombin time

Cefoperazone Sodium

Trade Name(s): Cefobid

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Third-generation cephalosporin

Accepted Indications: Septicemia, bone and joint infections, pelvic infections, intra-abdominal infections, gram-negative pneumonia, skin and soft tissue infections, uncomplicated urinary tract infections

Unaccepted Indications: Infections by Enterococci, Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermis or S. aureus

Mechanism of Action: Interferes with cell wall synthesis

Half life: 1.6–{endash}2.6 h

IM: 1–{endash}2 h

IV: End of infusion

Metabolism: Not metabolized

Elimination: Renal

Adult Dosage: Up to 12 g/d in 2 or 3 divided doses

Elderly Dosage: Lower dosage may be required

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Injection: 1 g/50 mL and 2 g/50 mL; sterile injection: 1 g (base), 2 g (base), and 10 g (base)

Frequent Side Effects: Oral candidiasis, GI reactions, vaginal candidiasis

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reactions, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like reactions, seizures, thrombophlebitis

Contraindications: Renal impairment, hepatic impairment

Antidotal Therapy: May include use of vancomycin for colitis caused by C. difficile infection

Compatibility of Solutions: Not compatible with aminoglycosides

Other Drugs: Alcohol, anticoagulants, heparin, thrombolytic agents, platelet aggregation inhibitors, nephrotoxic medications

Lab Tests: Urine glucose, Coombs' test

Cefotaxime Sodium

Trade Name(s): Claforan

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Third-generation cephalosporin

Accepted Indications: Gram-negative pneumonia, septicemia, bone and joint infections, pelvic infections, intra-abdominal infections, skin and soft tissue infections, complicated urinary tract infections, meningitis

Unaccepted Indications: Infections caused by enterococci, Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermis or S. aureus

Mechanism of Action: Interferes with cell wall synthesis

Absorption/Distribution: Widely distributed throughout the body

Half life: 1 h

IM: 0.5 h

Metabolism: Hepatic, renal

Elimination: Renal

Adult Dosage: Up to 12 g/d in 3 divided doses

Elderly Dosage: Lower dosage may be required

Child Dosage: Up to 50 kg: up to 180 mg/kg/d in 2–{endash}4 divided doses; 50 kg and over: same as adult dose

Infant Dosage: Same as child dose

Dosage Forms: Injection: 1 g (base)/50 mL and 2 g (base)/50 mL; sterile injection: 500 mg (base), 1 g (base), 2 g (base), and 10 g (base)

Warnings: Do not use if solution is cloudy or contains precipitate

Precautions: Solution may change color–{endash}does not affect potency

Frequent Side Effects: Oral candidiasis, GI reactions, vaginal candidiasis

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reactions, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like reactions, seizures, thrombophlebitis

Contraindications: Renal impairment, hepatic impairment

Antidotal Therapy: May include use of vancomycin for colitis caused by C. difficile infection

Compatibility of Solutions: Incompatible with aminoglycosides

Other Drugs: Alcohol, anticoagulants, heparin, thrombolytic agents, platelet aggregation inhibitors, probenecid, nephrotoxic medications

Lab Tests: BUN, Coombs' test

Cefotetan Disodium

Trade Name(s): Cefotan

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Second-generation cephalosporin

Accepted Indications: Septicemia, bone and joint infections, gram-negative pneumonia, skin and soft tissue infections, Bacteroides fragilis infections, aspiration pneumonia, diabetic foot infections, intra-abdominal and pelvic infections, perioperative infection prophylaxis, gonorrhea

Unaccepted Indications: Infections caused by Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermis or S. aureus, or enterococci

Mechanism of Action: Inhibits cell wall synthesis

Absorption/Distribution: Widely distributed throughout body

Half life: 3–{endash}4.6 h

IM: 1–{endash}3 h

IV: End of infusion

Metabolism: Not metabolized

Elimination: Renal

Adult Dosage: Mild to moderate infections: IV or IM, 1–{endash}2 g b.i.d. for 5–{endash}10 d; severe infections: IV, 2 g b.i.d.; life-threatening infections: IV, 3 g b.i.d.; perioperative prophylaxis: IV, 1–{endash}2 g 0.5–{endash}1 h before surgery; urinary tract infections: IM or IV, 500 mg–{endash}2 g b.i.d. or 1–{endash}2 g once daily

Elderly Dosage: Lower dose may be required

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Sterile injection: 1 g, 2 g, and 10 g

Warnings: Adjust dose for renal impairment; comply with full course of therapy

Precautions: Solutions range in color

Frequent Side Effects: GI reactions, oral candidiasis, vaginal candidiasis

Occasional Side Effects: Hypothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reaction, thrombophlebitis, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like syndrome, seizures

Antidotal Therapy: May include metronidazole, vancomycin for C. difficile infections

Compatibility of Solutions: Incompatible with aminoglycosides

Disease States: Bleeding disorders, GI disease, renal function impairment

Other Drugs: Alcohol, anticoagulants, probenecid, heparin, thrombolytic agents, platelet aggregation inhibitors

Lab Tests: Prothrombin time

Cefoxitin Sodium

Trade Name(s): Mefoxin

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, second-generation cephalosporin

Accepted Indications: Infections by anaerobic organisms, including septicemia, bone and joint infections, gram-negative pneumonia, skin and soft tissue infections, burn wound infections, and urinary tract infections; mixed aerobic-anaerobic bacterial infections, including aspiration pneumonia, diabetic foot infections, colorectal and appendectomy perioperative infections, and penicillin-resistant strains of gonorrhea

Unaccepted Indications: Infections caused by enterococci, Listeria species, Chlamydia

Mechanism of Action: Bactericidal, inhibits cell wall synthesis

Absorption/Distribution: Widely distributed, moderate protein binding

Half life: 0.7–{endash}1.1 h

IM: 0.3–{endash}0.5 h

IV: End of infusion

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: IV injection 1 g t.i.d. or q.i.d. up to 12 g/d

Elderly Dosage: May require changes in dosage

Child Dosage: 3 m and over: 13.3–{endash}26.7 mg/kg q4h

Infant Dosage: Up to 3 m: not established

Dosage Forms: Injection: 1 g/50 mL and 2 g/50 mL; sterile: 1 g, 2 g and 10 g

Warnings: Avoid alcohol

Precautions: Check with physician before taking antidiarrheals

Frequent Side Effects: Oral candidiasis, GI problems

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis, vaginitis

Rare Side Effects: Stevens-Johnson syndrome

Contraindications: Allergic reaction to penicillins or penicillin derivatives

Disease States: History of bleeding disorders; GI, liver, and kidney problems

Other Drugs: Alcohol, nephrotoxic medications, platelet-aggregation inhibitor, heparin, probenecid

Lab Tests: Coombs' test, blood glucose, prothrombin time, CBC, platelet count

Administrative Notes: Take with food if there is GI distress

Cefpodoxime

Trade Name(s): Vantin

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Third-generation cephalosporin

Accepted Indications: Gram-negative pneumonia, septicemia, bone and joint infections, pelvic infections, intra-abdominal infections, skin and soft tissue infections, complicated urinary tract infections, gonorrhea

Unaccepted Indications: Infections caused by enterococci, Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermis or S. aureus

Mechanism of Action: Interferes with cell wall synthesis

Absorption/Distribution: Widely distributed throughout the body

Half life: 2.1–{endash}2.8 h

PO: 2–{endash}3 h

Elimination: Renal

Adult Dosage: Bacterial bronchitis: 200 mg b.i.d. for 10 d; uncomplicated gonorrhea: 200 mg as a single dose; bacterial pharyngitis: 100 mg b.i.d. for 10 d; uncomplicated pneumonia: 200 mg b.i.d. for 14 d; skin and soft tissue infections: 400 mg b.i.d. for 7–{endash}14 d; uncomplicated urinary tract infections: 100 mg b.i.d. for 7 d

Elderly Dosage: Lower dosages may be required

Child Dosage: Up to 12 y: 5 mg/kg b.i.d. for 10 d

Infant Dosage: Up to 6 m: not established; 6 m and over: same as child dose

Dosage Forms: Tablets: 100 mg and 200 mg; oral suspension: 50 mg/5 mL and 100 mg/5 mL

Precautions: Take with food. Adjust dose for renal impairment, comply with full course of therapy

Frequent Side Effects: Oral candidiasis, GI reactions, vaginal candidiasis

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reactions, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like reaction, seizures, thrombophlebitis

Antidotal Therapy: May include metronidazole, vancomycin for colitis caused by C. difficile infection

Disease States: GI disease, renal function impairment

Other Drugs: Antacids, histamine H2-receptor agonists, platelet aggregation inhibitors, probenecid

Lab Tests: BUN, Coombs' test

Cefprozil

Trade Name(s): Cefzil

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, second-generation cephalosporin

Accepted Indications: Wide number of infections, including those caused by Escherichia coli, Klebsiella, and Proteus mirabilis; septicemia; bone and joint infections; gram-negative pneumonia

Unaccepted Indications: Infections caused by enterococci, Listeria species, Chlamydia

Mechanism of Action: Bactericidal, inhibits cell wall synthesis

Absorption/Distribution: High bioavailability

Half life: 1.3 h

PO: 1.5 h

Elimination: Renal

Adult Dosage: Oral 500 mg b.i.d. for 10 d

Elderly Dosage: Same as adult dose

Child Dosage: 6 m–{endash}12 y: 15 mg/kg every 12 h for 10 d (otitis media)

Infant Dosage: Up to 6 m: not established

Dosage Forms: For oral suspension: 125 mg/5 mL and 250 mg/5 mL; tablets: 250 mg and 500 mg

Warnings: Do not take antidiarrheals

Frequent Side Effects: Oral candidiasis

Occasional Side Effects: Unusual bleeding or bruising, vaginitis, rash

Rare Side Effects: Stevens-Johnson syndrome, serumlike sickness, itching, hypersensitivity

Contraindications: Reaction to penicillins

Antidotal Therapy: No specific antidote; may include supportive and symptomatic treatment

Disease States: Bleeding disorders, GI and liver/kidney problems, phenylketonuria

Other Drugs: Alcohol, thrombolytic agents, probenecid, platelet-aggregation inhibitors

Lab Tests: Coombs' test, blood glucose, prothrombin time, BUN, CBC, bilirubin

Administrative Notes: Include calibrated device with oral suspension

Ceftazidime

Trade Name(s): Ceptaz, Fortaz, Tazicef, Tazidime

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, third-generation cephalosporin

Accepted Indications: Wide spectrum of gram-negative bacterial infections, including septicemia, bone and soft tissue infections, burn wounds, urinary tract infections

Unaccepted Indications: Infections caused by enterococcal, Listeria species, Chlamydia

Mechanism of Action: Bactericidal; inhibits cell wall synthesis

Absorption/Distribution: Low protein binding; widely distributed, including CNS

Half life: 2 h

IM: 1 h

IV: End of infusion

Elimination: Renal

Research Notes: 3rd generation cephalosporin

Adult Dosage: 250 mg–{endash}2 g b.i.d. to t.i.d. by IV or IM

Elderly Dosage: Adjust dosage if renal impairment

Child Dosage: 1 m–{endash}12 y: IV infusion 30–{endash}50 mg/kg t.i.d.

Infant Dosage: Neonates up to 4 w: IV infusion 30 mg/kg b.i.d.

Dosage Forms: Injection: 1 g/50 mL or 2 g/50 mL; for injection 500 mg, 1 g, 2 g, 6 g and 10 g

By System: Systemic

Warnings: Avoid alcohol; do not miss doses

Precautions: Do not take antidiarrheals

Frequent Side Effects: Oral candidiasis

Occasional Side Effects: Hypoprothrombinemia, vaginitis

Rare Side Effects: Stevens-Johnson syndrome

Contraindications: Previous allergic reaction to penicillins and penicillamines

Antidotal Therapy: No specific antidote; may include supportive treatment

Disease States: Bleeding disorders; GI, liver, and kidney problems; phenylketonuria

Other Drugs: Thrombolytic agents, alcohol, probenecid, nephrotoxic medications, anticoagulants

Lab Tests: Blood and urine glucose, BUN, CBC, platelet count, Coombs' test

Administrative Notes: Incompatible with vancomycin; if given with aminoglycosides, do not mix together; take with food after GI upset.

Ceftizoxime Sodium

Trade Name(s): Cefizox

Pregnancy Category: B

Medical Category: Systemic antibacterial, third-generation cephalosporin

Accepted Indications: Serious gram-negative bacterial infections, septicemia, bone and joint infections, pelvic infections, intra-abdominal infections, gram-negative pneumonia, skin and soft tissue infections, complicated urinary tract infections, Enterococci, Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermis or S. aureus

Mechanism of Action: Inhibits bacterial cell wall synthesis

Absorption/Distribution: Widely distributed throughout most tissues

Half life: 1.7 h (IM)

IM: 1 h

IV: End of infusion

Elimination: Renal

Adult Dosage: IV: 1–{endash}4 g t.i.d.

Child Dosage: 50 mg/kg t.i.d. to q.i.d.

Infant Dosage: Under 6 m: not established; 6 m and over: IV, 50 mg/kg t.i.d. to q.i.d.

Dosage Forms: Injection: 1 g/50 mL and 2 g/50 mL; sterile injection: 1 g, 2 g, and 10 g

Compatibility of Solutions: Incompatible with aminoglycosides

Other Drugs: Alcohol

Administrative Notes: Do not use if cloudy or contains precipitate

Ceftriaxone Sodium

Trade Name(s): Rocephin

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, third-generation cephalosporin

Accepted Indications: Wide spectrum of gram-negative bacterial infections, including septicemia, soft tissue and bone infections, burn wounds, urinary tract infections

Unaccepted Indications: Infections caused by enterococci, Listeria species, Chlamydia

Mechanism of Action: Bactericidal; inhibits cell wall synthesis

Half life: IM, 5.8–{endash}8.7 h; IV, 4.3–{endash}4.6 h

IM: 2.3 h

IV: End of infusion

Elimination: Renal

Research Notes: 3rd generation cephalosporin

Adult Dosage: IV: 1–{endash}2 g once daily up to limit of 4 g

Elderly Dosage: Adjust dosage if renal impairment

Child Dosage: IV: 25–{endash}37.5 mg/kg every 12 h

Infant Dosage: Same as child dose

Dosage Forms: Injection: 1 g/50 mL and 2 g/50 mL; sterile ceftriaxone sodium: 250 mg, 500 mg, 1 g, 2 g, and 10 g

Warnings: Avoid alcohol

Precautions: Do not take antidiarrheals

Frequent Side Effects: Oral candidiasis

Occasional Side Effects: Hypoprothrombinemia, vaginitis

Rare Side Effects: Stevens-Johnson syndrome, rash, hypersensitivity, formation of biliary sludge

Contraindications: Previous allergic reaction to penicillin and penicillamine

Antidotal Therapy: No specific antidote; may include supportive treatment

Disease States: Bleeding disorders; GI, liver and kidney problems; phenylketonuria

Other Drugs: Thrombolytic agents, alcohol, probenecid, nephrotoxic medications, anticoagulants

Lab Tests: Blood and urine glucose, BUN, CBC, platelet count, Coombs' test

Administrative Notes: Do not mix with antibacterials in IV bag

Cefuroxime Cefuroxime

Trade Name(s): Ceftin, Kefurox, Zinacef

Chemically Related To: Cephalosporins

Scheduled Class: Systemic antibacterial

Pregnancy Category: B

Medical Category: Second-generation cephalosporin

Accepted Indications: Septicemia, bone and joint infections, gram-negative pneumonia, skin and soft tissue infections, urinary tract infections, community-acquired pneumonia, meningitis, otitis media, sinusitis, bronchitis, gonococcal urethritis

Unaccepted Indications: Infections caused by enterococci, Listeria, Chlamydia, Clostridium difficile, and methicillin-resistant Staphylococcus epidermidis, Staphylococcus aureus

Mechanism of Action: Bactericidal; inhibits protein synthesis

Absorption/Distribution: Widely distributed, including CSF

Half life: 1.3 h

PO: 2 h

IM: 0.75 h

IV: End of infusion

Metabolism: Not metabolized

Elimination: Renal

Adult Dosage: Tablets: 250–{endash}500 mg b.i.d.; injection and sterile: IM or IV, 750 mg–{endash}1.5 g t.i.d.

Elderly Dosage: Lower dosage may be required

Child Dosage: Tablets up to 12 y: 125 mg b.i.d., 12 y and over: same as adult dose; injection and sterile: 3 m and over: IM or IV, 16.7–{endash}33.3 mg.kg t.i.d.

Infant Dosage: Tablets: up to 3 m: not established; 3 m and over: 125 mg b.i.d.; injection and sterile: neonates: IM or IV, 10–{endash}33.3 mg/kg t.i.d.; 3 m and over: IM or IV, 16.7–{endash}33.3 mg/kg t.i.d.

Dosage Forms: Tablets: 125 mg, 250 mg, and 500 mg; injection: 750 mg/50 mL and 1.5 g/50 mL; sterile: 750 mg, 1.5 g, and 7.5 g

Frequent Side Effects: Oral candidiasis, GI upset, vaginal candidiasis

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis, stomach cramps, vaginitis

Rare Side Effects: Allergic reactions, Stevens–{endash}Johnson syndrome, convulsions, thrombophlebitis, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like reactions

Contraindications: Allergic reactions to penicillins, penicillamine

Antidotal Therapy: May include symptomatic and supportive treatment

Compatibility of Solutions: Incompatible with aminoglycosides

Disease States: Bleeding disorders; GI, liver, or kidney problems

Other Drugs: Probenecid, platelet-aggregation inhibitors

Lab Tests: Coombs' test, blood glucose, BUN, CBC, platelet count, bilirubin

Administrative Notes: Take with food if there is GI discomfort. If convulsions occur, discontinue drug.

Cephalexin

Trade Name(s): Cefanex, Keflex

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, first-generation cephalosporin

Accepted Indications: Septicemia, bone and joint infections, otitis media, pneumonia, skin and soft tissue infections, burn wound infections, urinary tract infections

Unaccepted Indications: Infections caused by enterococci, Listeria, Chlamydia, Clostridium difficile

Mechanism of Action: Bactericidal

Absorption/Distribution: High bioavailability; widely distributed

Half life: 0.9–{endash}1.2 h

PO: 1 h

Elimination: Renal

Research Notes: First generation cephalosporin

Adult Dosage: 250–{endash}500 mg q.i.d. up to 4 g/d

Elderly Dosage: Dosage adjustment suggested

Child Dosage: 6.25–{endash}25 mg/kg q.i.d.

Infant Dosage: Prolonged half-life in infants

Dosage Forms: Capsules: 250 mg and 500 mg; tablets: 250 mg and 500 mg; oral suspension: 100 mg/mL, 125 mg/5 mL, and 250 mg/5 mL

Warnings: Continue medication for full time of treatment

Precautions: If seizures occur, discontinue medication

Frequent Side Effects: Oral candidiasis, GI problems

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis, vaginitis

Rare Side Effects: Stevens-Johnson syndrome, convulsions, thrombophlebitis, allergy

Contraindications: Allergic reaction to penicillin, penicillamine

Antidotal Therapy: May include symptomatic and supportive treatment

Disease States: History of bleeding disorders or GI problems, liver and kidney problems, phenylketonuria

Nutrition: Take with food if GI irritation occurs

Other Drugs: Alcohol, thrombolytic agents, probenecid, anticoagulants, nephrotoxic medications

Lab Tests: Prothrombin time, urine protein, blood glucose, antiglobulin tests, platelet count, BUN

Administrative Notes: Suspensions retain their potency for 14 d if refrigerated

Cephalothin Sodium

Trade Name(s): Keflin

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: First-generation cephalosporin

Accepted Indications: Septicemia, skin and soft tissue infections, pneumonia, otitis media, bone and joint infections, urinary tract infections

Unaccepted Indications: Infections caused by Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermidis, or S. aureus or enterococci

Mechanism of Action: Interferes with cell wall synthesis

Absorption/Distribution: Widely distributed throughout body

Half life: 0.5–{endash}1 h

IM: 0.5 h

IV: 0.25–{endash}0.5 h

Metabolism: Hepatic, renal

Elimination: Renal

Adult Dosage: Antibacterial: IV infusion, 500 mg–{endash}2 g q4–{endash}6h; perioperative prophylaxis: IV infusion, 1–{endash}2 g 0.5–{endash}1 h before surgery, 1–{endash}2 g during surgery, 1–{endash}2 g q.i.d. for up to 24 h; pneumonia, furunculosis, and urinary tract infections: IV infusion, 500 mg q.i.d.

Elderly Dosage: Lower dosage may be needed

Child Dosage: Antibacterial: IV infusion, 13.3–{endash}26.6 mg/kg q4h or 20–{endash}40 mg/kg q.i.d.; perioperative prophylaxis: IV infusion, 20–{endash}30 mg/kg 0.5–{endash}1 h before surgery, 20–{endash}30 mg/kg during surgery, 20–{endash}30 mg/kg q.i.d. for up to 24 h

Dosage Forms: Injection: 1 g/50 mL and 2 g/50 mL; for injection: 1 g and 2 g

Warnings: Adjust dose for renal impairment; comply with full course of therapy

Frequent Side Effects: GI reactions, oral candidiasis, vaginal candidiasis

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reaction, thrombophlebitis, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like syndrome, seizures

Antidotal Therapy: May include metronidazole, vancomycin for C. difficile infections

Compatibility of Solutions: Incompatible with aminoglycosides

Disease States: GI disease, renal function impairment

Other Drugs: Nephrotoxic medications, platelet aggregation inhibitors, probenecid

Lab Tests: Prothrombin time

Administrative Notes: If precipitate forms, shake solution

Cephapirin Sodium

Trade Name(s): Cefadyl

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: First-generation cephalosporin

Accepted Indications: Septicemia, skin and soft tissue infections, pneumonia, otitis media, bone and joint infections, urinary tract infections

Unaccepted Indications: Infections caused by Listeria, Chlamydia, Clostridium difficile, methicillin-resistant Staphylococcus epidermidis or S. aureus, or enterococci

Mechanism of Action: Inhibits cell wall synthesis

Absorption/Distribution: Widely distributed throughout body

Half life: 0.5–{endash}0.8 h

IM: 0.5–{endash}1 h

IV: End of infusion

Metabolism: Hepatic, renal

Elimination: Renal

Adult Dosage: Antibacterial: IV or IM, 500 mg–{endash}1 g q4–{endash}6h; perioperative prophylaxis: IM or IV, 1–{endash}2 g 0.5–{endash}1 h before surgery, 1–{endash}2 g during surgery, 1–{endash}2 g q.i.d. for up to 24 h

Elderly Dosage: Lower dosage may be required

Child Dosage: IM or IV: 10–{endash}20 mg/kg q.i.d.

Infant Dosage: Up to 3 m: not established; 3 m and over: IM or IV, 10–{endash}20 mg/kg q.i.d.

Dosage Forms: Sterile injection: 500 mg, 1 g, 2 g, 4 g, and 20 g

Warnings: Adjust dose for renal impairment; comply with full course of therapy

Frequent Side Effects: GI reactions, oral candidiasis, vaginal candidiasis

Occasional Side Effects: Hypoprothrombinemia, pseudomembranous colitis

Rare Side Effects: Allergic reaction, thrombophlebitis, Stevens-Johnson syndrome, hemolytic anemia, hypersensitivity, renal dysfunction, serum sickness–{endash}like syndrome, seizures

Antidotal Therapy: May include metronidazole, vancomycin for C. difficile infections

Compatibility of Solutions: Incompatible with aminoglycosides

Disease States: GI disease

Other Drugs: Platelet aggregation inhibitors, probenecid

Lab Tests: Prothrombin time

Cephradine

Trade Name(s): Velosef

Chemically Related To: Cephalosporins

Pregnancy Category: B

Medical Category: Antibacterial, first-generation cephalosporin

Accepted Indications: Septicemia, bone infections, otitis media, pneumonia, skin infections, burn infections, and urinary tract infections

Unaccepted Indications: Infections caused by enterococci, Listeria species, Chlamydia, Clostridium difficile, or methicillin-resistant staphylococcal infections

Mechanism of Action: Inhibits cell wall synthesis of bacteria; cell growth and division also inhibited

Absorption/Distribution: Well absorbed

Half life: 0.8–{endash}1.3 h (8–{endash}15 h with impaired renal function)

Peak activity: 1 h

PO: 1 h, delayed in presence of food

IM: 0.8–{endash}2 h

IV: End of infusion

Metabolism: Mostly excreted unchanged

Elimination: Renal 60%–{endash}80%

Research Notes: With impaired renal function, reduction in dose suggested

Adult Dosage: 1–{endash}4 g/d

Elderly Dosage: Same as adult dose

Child Dosage: 6.25–{endash}25 mg/kg q.i.d.

Infant Dosage: 25 mg/kg q.i.d. up to 4 g/d

Dosage Forms: Capsules: 250 mg and 500 mg; oral suspension: 125 mg/5 mL and 250 mg/5 mL; for injection: 250 mg, 500 mg, 1g, and 2 g

Precautions: For severe diarrhea, check with physician before taking any antidiarrheals; if seizures occur, discontinue medication

Frequent Side Effects: Oral candidiasis, GI reaction

Occasional Side Effects: Vaginitis

Rare Side Effects: Hypoprothrombinemia, pseudomembranous colitis, seizures

Antidotal Therapy: No specific antidote; may include symptomatic and supportive treatment

Disease States: Bleeding disorders, GI disease, renal function impairment

Nutrition: Take with food if GI irritation occurs

Other Drugs: Alcohol, anticoagulants, heparin, thrombolytic agents, platelet–{endash}aggregation inhibitors, probenecid

Lab Tests: Coombs' test, glucose, prothrombin time

Administrative Notes: In some patients, antibiotic–{endash}associated pseudomembranous colitis possible during or after administration; in mild cases, discontinue drug; in moderate to severe cases, fluids, electrolytes, and protein replacement suggested

Chenodiol

Trade Name(s): Chenix

Pregnancy Category: X

Medical Category: Anticholelithic

Accepted Indications: Gallstone disease (small, radiolucent stones with functioning gallbladder)

Mechanism of Action: Evokes desaturation of the bile by increasing the ratio of bile acids to cholesterol

Absorption/Distribution: Well absorbed from small intestine

PO: 50–{endash}120 min

Metabolism: Hepatic; first-pass hepatic clearance

Elimination: Fecal

Research Notes: More likely to be successful if stones are small and floatable

Adult Dosage: 13–{endash}16 mg/kg/d

Elderly Dosage: Same as adult dose

Dosage Forms: Tablets: 250 mg

By System: Hepatic, bile

Precautions: Do not take aluminum–{endash}containing antacids

Frequent Side Effects: Diarrhea

Occasional Side Effects: Constipation, gas, indigestion, nausea and vomiting, stomach cramps or pain

Rare Side Effects: Diarrhea, severe dehydration

Overdosage: Severe diarrhea

Antidotal Therapy: May include gastric lavage followed by 50 mL of aluminum hydroxide suspension

Disease States: Atherosclerosis, bile duct abnormalities, gallstone complications, hepatic function impairment

Other Drugs: Aluminum–{endash}containing antacids, cholestyramine, estrogens, neomycin, progestins, antihyperlipidemics

Lab Tests: Cholesterol

Administrative Notes: Chenodiol therapy considered failed if dissolution has not occurred after 9–{endash}12 m of treatment

Chloral Hydrate

Trade Name(s): Noctec

Chemically Related To: Ethyl alcohol

Scheduled Class: IV

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Sedative-hypnotic

Accepted Indications: Preoperative anxiety (adjunct anesthesia); postoperative analgesia (adjunctive management); insomnia; short-term sedation (has generally been replaced by safer, more effective agents)

Mechanism of Action: CNS depressant

Absorption/Distribution: Readily absorbed from GI tract

Half life: Metabolite: 7–{endash}10 h

PO: 30 min

Metabolism: Liver to active metabolites: trichloro-ethanol

Elimination: Renal

Adult Dosage: Hypnotic: 500 mg–{endash}1 g 15–{endash}30 min before bedtime, sedative AM, 250 t.i.d. after meals, preoperative 500 mg–{endash}1 g 30 min before surgery

Elderly Dosage: Age-related hepatic and renal function impairment may require reduction in dose

Child Dosage: Premedication before dental or medical procedures, 50 mg/kg up to a maximum of 1 g per single dose. Total dose should not exceed 100 mg/kg or 2 g; premedication before EEG evaluation, 25 mg/kg

Infant Dosage: Same as child dose

Dosage Forms: Capsules 250 and 500 mg, syrup 250 and 500 mg

By System: CNS depressant

Warnings: Tolerance with continual administration

Precautions: Avoid use of alcohol or other CNS depressants

Frequent Side Effects: Nausea, stomach pain, vomiting

Occasional Side Effects: Clumsiness or unsteadiness, diarrhea, drowsiness

Rare Side Effects: Confusion, hallucinations, unusual excitement, allergic reaction

Overdosage: Confusion; convulsions; difficulty in swallowing, drowsiness, hypothermia; severe nausea, vomiting, or stomach pain; arrhythmia

Antidotal Therapy: May include gastric lavage; maintain respiration, circulation, and normal body temperature; continuous cardiac monitoring; appropriate fluid and electrolyte therapy

Disease States: Severe cardiac disease, gastritis, severe hepatic function impairment, colitis

Other Drugs: Alcohol, CNS depressants, anticoagulants, IV furosemide

Lab Tests: Urine glucose determinations

Chlorambucil

Trade Name(s): Leukeran

Chemically Related To: Nitrogen mustard

Pregnancy Category: D

Medical Category: Antineoplastic, immunosuppressant

Accepted Indications: Chronic lymphocytic leukemia, Hodgkin's or non-Hodgkin's lymphomas

Mechanism of Action: Cross-linking of DNA and RNA; inhibition of protein synthesis

Absorption/Distribution: Completely absorbed from GI tract

Half life: 1.5 h; metabolite, 2.5 h

PO: 1 h

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: 100–{endash}200 m{mu}g/kg/d as a single dose or in divided doses; maximum recommended cumulative dose of 14 mg/kg or maximum duration of treatment 12 w

Elderly Dosage: Same as adult dose

Child Dosage: Same as adult dose

Dosage Forms: Tablets: 2 mg

By System: Hematopoietic

Warnings: Withdraw if signs of pulmonary toxicity occur

Precautions: Avoid immunizations

Frequent Side Effects: Pancytopenia, immunosuppression, thrombocytopenia

Occasional Side Effects: Black, tarry stools; cough or hoarseness; fever or chills; sores in mouth and on lips; joint pain; itching

Rare Side Effects: Agitation, confusion, convulsions, hallucinations, muscle twitching, jaundiced eyes or skin, drug fever, hepatic necrosis, pulmonary fibrosis

Overdosage: Reversible pancytopenia, ataxia, agitation, seizures

Antidotal Therapy: May include supportive and symptomatic treatment; monitoring of blood counts 3 times/w for at least 3 w

Disease States: Viral and bacterial infections, convulsions, head injury, gout, kidney stones, bone marrow depression

Other Drugs: Corticosteroids, probenecid, amphotericin B, colchicine, interferon, zidovudine, live virus vaccines

Lab Tests: Alkaline phosphatase, uric acid in blood and urine

Chloramphenicol

Trade Name(s): Chloromycetin

Pregnancy Category: Not documented, but not recommended

Medical Category: Systemic antibacterial

Accepted Indications: Infections caused by gram-positive and gram-negative bacteria, anaerobic bacteria, rickettsiae, spirochetes, Chlamydia

Unaccepted Indications: Routine typhoid carrier states, trivial infections, colds, influenza, or throat infections

Mechanism of Action: Bacteriostatic; inhibits protein synthesis

Absorption/Distribution: Rapidly and completely absorbed; widely distributed

Half life: 1.5–{endash}3.5 h

PO: 1–{endash}3 h

IV: 1–{endash}1.5 h

Metabolism: Hepatic

Elimination: Renal, fecal/biliary

Research Notes: Should be reserved for serious infections

Adult Dosage: 12.5 mg/kg up to 4 g systemically; otic solution: 2 or 3 drops to the ear canal q6–{endash}8h

Elderly Dosage: Same as adult dose

Child Dosage: Over 2 w: 12.5 mg/kg q.i.d.

Infant Dosage: Up to 2 w: 6.25 mg/kg q.i.d.

Dosage Forms: Capsules: 250 mg; oral suspension: 150 mg/5 mL; sterile USP: 1 g; otic solution: 0.5%

Precautions: In neonates or fetus, can cause gray baby syndrome, which can be fatal

Occasional Side Effects: Blood dyscrasias, diarrhea, nausea/vomiting

Rare Side Effects: Gray baby syndrome, neurotoxic reactions, rash

Disease States: Bone marrow depression, liver problems, radiation therapy

Other Drugs: Erythromycin, hepatic enzyme inducers, warfarin, estrogen–{endash}containing contraceptives, bone marrow depressants, warfarin, phenobarbitone, phenytoin

Lab Tests: Urine glucose determination, bentiromide

Chloramphenicol/Desoxyribonuclease/Fibrinolysin

Trade Name(s): Elase-Chloromycetin

Medical Category: Wound debridement

Accepted Indications: Wound healing

Adult Dosage: Apply at least once daily

Dosage Forms: Ointment: 10 mg/666.6 units/1 unit/g

Chloramphenicol/Hydrocortisone Acetate/Polymyxin B Sulfate

Trade Name(s): Ophthocort

Medical Category: Anti-infective

Accepted Indications: Ophthalmic infections

Adult Dosage: Apply ointment to the eye every 3–{endash}4 h

Dosage Forms: Ointment, ophthalmic: 1%/0.5%/10,000 units

Chlorcyclizine Hydrochloride

Trade Name(s): Not available as a single agent

Chemically Related To: Antihistamines

Pregnancy Category: C

Medical Category: Antihistamine

Mechanism of Action: H1 histamine receptor antagonist

By System: Dermal

Contraindications: Tuberculosis of skin, herpes simplex

Chlorcyclizine Hydrochloride/Hydrocortisone Acetate

Trade Name(s): Mantadil

Pregnancy Category: C

Medical Category: Anti-inflammatory, antipruritic, anesthetic

Accepted Indications: Inflammation

Adult Dosage: Apply to skin 2–{endash}5 times/d

Dosage Forms: Cream: 2%/0.5%

Chlordiazepoxide Hydrochloride Chlordiazepoxide Hydrochloride

Trade Name(s): Libritabs, Librium, Lipoxide

Chemically Related To: Benzodiazepines

Scheduled Class: IV

Abuse Potential: Minor

Pregnancy Category: Not established

Medical Category: Antianxiety agent, sedative-hypnotic, antipanic agent, antitremor agent

Accepted Indications: Anxiety, alcohol withdrawal, anesthesia (adjunctive management), panic disorder, tension headache, tremor

Mechanism of Action: Enhances inhibitory GABA

Absorption/Distribution: Well absorbed

Half life: 5–{endash}30 h

PO: 0.5–{endash}4 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Accumulation of drug significant during repeated dosing

Adult Dosage: 5–{endash}25 mg t.i.d. or q.i.d. up to 400 mg/d

Elderly Dosage: 5 mg b.i.d. to q.i.d.

Child Dosage: Up to 6 y: safety not established; over 6 y: 5 mg b.i.d. to q.i.d. up to 10 mg b.i.d. or t.i.d.

Infant Dosage: Safety not established

Dosage Forms: Tablets: 5 mg, 10 mg, and 25 mg; capsules 5 mg, 10 mg, and 25 mg; sterile USP: 100 mg

By System: CNS

Warnings: May cause drowsiness; avoid alcohol

Frequent Side Effects: Ataxia, dizziness, drowsiness, slurred speech, irritability, insomnia

Occasional Side Effects: Depression, stomach cramps, headache, nausea/vomiting, trembling, weakness

Rare Side Effects: Blood dyscrasias, neutropenia, anemia, muscle weakness, memory impairment, dependence, withdrawal symptoms

Overdosage: Confusion, decreased reflexes, drowsiness, bradycardia, slurred speech, weakness

Antidotal Therapy: Supportive treatment: may include emesis/gastric lavage, activated charcoal; monitoring respiration and blood pressure; oxygen administration; IV vasopressors, flumazenil

Disease States: Alcohol, coma, seizures, glaucoma, liver or kidney problems, myasthenia gravis, depression, sleep apnea

Other Drugs: CNS depressants, tricyclic antidepressants, zidovudine, scopolamine, rifampin, levodopa

Lab Tests: Metyrapone, sodium iodide I 123 and sodium iodide I 131

Administrative Notes: After reconstitution, use sterile USP solution at once; do not heat

Chlordiazepoxide Hydrochloride/Clidinium Bromide

Trade Name(s): CDP Plus, Cl, Clinoxide, Librax, Lidox, Lidoxide, Spazmate, Zebrax

Pregnancy Category: Use not recommended

Medical Category: Antispasmodic, anxiolytic

Accepted Indications: Peptic ulcer, gastrointestinal irritability (possibly effective)

Adult Dosage: 1–{endash}2 capsules once daily to q.i.d., 30–{endash}60 min before food

Elderly Dosage: Maximum of 1 capsule b.i.d.

Child Dosage: Not established

Dosage Forms: Capsules: 5 mg/2.5 mg

Side/Adverse Effects: Agranulocytosis, granulocytopenia, leukopenia, allergic reaction, increased intraocular pressure, CNS depression, jaundice, paradoxical reaction

Disease States: Cardiac disease, glaucoma, hiatal hernia with reflux, esophagitis, hepatic disease, myasthenia gravis, ulcerative colitis, intestinal atony, obstruction in GI or urinary tract

Other Drugs: Anticholinergics, antacids, CNS depressants, antidiarrheals, ketoconazole, potassium chloride

Chlordiazepoxide/Estrogens, Esterified

Trade Name(s): Menrium 5-2, 5-4, 10-4

Pregnancy Category: C

Medical Category: Antianxiety, estrogen replacement

Accepted Indications: Menopause

Adult Dosage: 1 tablet t.i.d. in 21 d courses, followed by a 1 w rest period

Dosage Forms: Tablets: 5 mg/0.2 mg, 5 mg/0.4 mg, and 10 mg/0.4 mg

Chlorhexidine Gluconate

Trade Name(s): Peridex

Chemically Related To: Hexachlorophene

Pregnancy Category: B

Medical Category: Dental antibacterial

Accepted Indications: Gingivitis, mouth infections, denture stomatitis, some staphylococcal infections, dental plaque

Mechanism of Action: Bacteriostatic; leakage of cell wall parts

Absorption/Distribution: 30% released into oral fluids; poorly absorbed from GI tract

Elimination: Fecal/renal

Research Notes: Once drug is discontinued, plaque returns to normal levels

Adult Dosage: Topical to gingival membranes 15 mL for 0.5 min b.i.d.

Elderly Dosage: Same as adult dose

Child Dosage: Not established

Dosage Forms: Oral rinse: 0.12%

By System: Oral cavity

Warnings: Do not swallow or dilute

Precautions: Use medication after brushing and flossing; swish drug around in mouth for 30 sec

Frequent Side Effects: Change in taste, staining of teeth

Occasional Side Effects: Mouth irritation, irritation of tip of tongue

Disease States: Front-tooth fillings, periodontitis

Administrative Notes: Give patient package insert; dispense in original container; protect from light

Chlormezanone

Trade Name(s): Trancopal

Chemically Related To: Meprobamate

Medical Category: Antianxiety agent

Accepted Indications: Anxiety

Mechanism of Action: Inhibits Cl-{minus} movement into cells

Absorption/Distribution: Rapidly absorbed from GI tract

Half life: 24 h

PO: 1–{endash}2 h

Metabolism: Hepatic

Elimination: Renal, fecal

Research Notes: Duration of action up to 6 h or longer

Adult Dosage: 100–{endash}800 mg/d in 2 or 3 divided doses

Elderly Dosage: Age-related liver and kidney malfunction may necessitate lower dose

Child Dosage: 100–{endash}300 mg/d

Infant Dosage: Not established

Dosage Forms: Tablets: 100 mg and 200 mg

By System: Subcortical nuclei of the CNS

Warnings: May cause drowsiness; avoid alcoholic beverages

Frequent Side Effects: Drowsiness

Occasional Side Effects: Confusion, mental depression, difficult urination, dizziness, headache, nausea, trembling

Rare Side Effects: Cholestatic jaundice, swelling of feet or lower legs, extreme excitement

Overdosage: Confusion, drowsiness, loss of reflexes, continuing tiredness or weakness

Antidotal Therapy: May include general supportive therapy

Disease States: Hepatic or renal function impairment

Other Drugs: Alcohol or CNS depressants

Administrative Notes: Withdrawal symptoms have been reported rarely

Chloroquine Hydrochloride

Trade Name(s): Aralen HCl

Chemically Related To: Quinine

Pregnancy Category: Not recommended

Medical Category: Antiprotozoal

Accepted Indications: Malaria, amebic liver abscess, solar urticaria, chronic cutaneous vasculitis, lupus erythematosus, rheumatoid arthritis

Unaccepted Indications: Prevention of Plasmodium virax or P. ovale malaria relapse, acute amebic dysentery or asymptomatic carriers

Mechanism of Action: Inhibits the erythrocytic stage of the development of plasmodia

Absorption/Distribution: Almost completely absorbed from GI tract; widely distributed in body tissues

Half life: 1–{endash}2 m (terminal elimination)

IM: 0.5 h

IV: 0.5 h

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: Varies by indication

Elderly Dosage: Same as adult dose

Child Dosage: Varies by indication

Infant Dosage: Same as child dose

Dosage Forms: Injection: 50 mg/mL

Warnings: Children are especially sensitive to chloroquine effects

Frequent Side Effects: Ciliary muscle dysfunction, GI irritation, headache, itching

Occasional Side Effects: Ocular toxicity, hair loss, bleaching of hair, rash

Rare Side Effects: Blood dyscrasias, aplastic anemia, neutropenia, thrombocytopenia, cardiovascular toxicity, psychosis, neuromyopathy, ototoxicity, seizures

Overdosage: Cardiovascular toxicity, neurotoxicity, respiratory and cardiac arrest, visual disturbances

Antidotal Therapy: May include securing of airway, oxygen, gastric lavage, activated charcoal, cathartic, diazepam, fluids

Disease States: Severe blood disorders, severe GI disorders, G6PD deficiency, hepatic function impairment, neurological disorders, psoriasis, porphyria, retinal or visual field changes

Other Drugs: Penicillamine

Administrative Notes: Toxic symptoms within 30 min; fatalities reported as soon as 3 h post ingestion

Chloroquine Phosphate

Trade Name(s): Aralen Phosphate

Chemically Related To: Quinine

Pregnancy Category: Not recommended

Medical Category: Antiprotozoal, antihypercalcemic, antirheumatic, lupus erythematosus suppressant, polymorphous light eruption suppressant, porphyria cutanea tarda suppressant

Accepted Indications: Malaria, amebic liver abscess, juvenile arthritis, rheumatoid arthritis, hypercalcemia, lupus erythematosus, polymorphous light eruption, porphyria cutanea tarda, solar urticaria, chronic cutaneous vasculitis

Unaccepted Indications: Prevention of Plasmodium virax or P. ovale malaria relapse, acute amebic dysentery or asymptomatic carriers

Mechanism of Action: Inhibits the erythrocytic stage of the development of plasmodia

Absorption/Distribution: Almost completely absorbed from GI tract, widely distributed in body tissues

Half life: 1–{endash}2 m (terminal elimination)

PO: 3.5 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Doses as small as 300 mg in children and 2.5 g in adults potentially fatal

Adult Dosage: Varies by indication

Elderly Dosage: Varies by indication

Child Dosage: Varies by indication

Infant Dosage: Same as child dose

Dosage Forms: Tablets: 250 mg and 500 mg

Warnings: Children are especially sensitive to chloroquine effects

Frequent Side Effects: Ciliary muscle dysfunction, GI irritation, headache, itching

Occasional Side Effects: Ocular toxicity, hair loss, bleaching of hair, blue-black skin discoloration, rash

Rare Side Effects: Blood dyscrasias, aplastic anemia, neutropenia, thrombocytopenia, cardiovascular toxicity, psychosis, neuromyopathy, ototoxicity, seizures

Overdosage: Cardiovascular toxicity, neurotoxicity, respiratory and cardiac arrest, visual disturbances

Antidotal Therapy: May include securing of airway, oxygen, gastric lavage, activated charcoal, cathartic, diazepam, fluids

Disease States: Severe blood disorders, severe GI disorders, G6PD deficiency, hepatic function impairment, neurological disorders, porphyria, psoriasis, retinal or visual field changes

Other Drugs: Penicillamine

Administrative Notes: Toxic symptoms occur within 30 min; fatalities reported as soon as 3 h post ingestion

Chlorothiazide

Trade Name(s): Diuril

Chemically Related To: Hydrochlorothiazide

Pregnancy Category: B

Medical Category: Diuretic, antihypertensive, antidiuretic (diabetes insipidus), antiurolithic (calcium calculi)

Accepted Indications: Edema, hypertension, diabetes insipidus, renal calcium calculi (prophylaxis)

Mechanism of Action: Inhibits sodium reabsorption in nephron

Absorption/Distribution: Rapid absorption

Half life: 13 h

Peak activity: 4 h

Elimination: Renal, bile

Research Notes: Onset of action, 2 h; duration of action, 6–{endash}12 h

Adult Dosage: 250 mg–{endash}1 g/d

Elderly Dosage: More sensitive to hypotensive effect

Child Dosage: Over 6 m: 10–{endash}20 mg/kg/d

Infant Dosage: Up to 6 m: 10–{endash}30 mg/kg/d

Dosage Forms: Oral suspension 50 mg/mL, tablets 250 and 500 mg

By System: Renal

Warnings: Shake suspension well; avoid sun/sun lamp

Precautions: Take medication even if symptoms disappear; may increase blood glucose levels

Frequent Side Effects: Electrolyte imbalance, hypokalemia

Occasional Side Effects: Anorexia, diarrhea, photosensitivity, orthostatic hypotension, nausea

Rare Side Effects: Agranulocytosis, thrombocytopenia, gout, glucose intolerance, rash

Antidotal Therapy: May include emesis/gastric lavage, monitor serum electrolytes and kidney function

Disease States: Anuria or severe renal impairment, lupus erythematosus, hypercalcemia

Other Drugs: Lithium, sympathomimetics, digitalis glycosides, NSAIDs, antihypertensives, neuromuscular blocking agents

Lab Tests: Uric acid, bilirubin, phentolamine, tyramine, glucose (blood and urine), cholesterol

Administrative Notes: Sodium restriction

Chlorothiazide/Methyldopa

Trade Name(s): Aldoclor 150, 250

Pregnancy Category: B

Medical Category: Antihypertensive

Accepted Indications: Hypertension

Adult Dosage: 2–{endash}4 tablets once daily

Child Dosage: As determined by individual titration

Dosage Forms: Tablets: 150 mg/250 mg, 250 mg/250 mg

Chlorotrianisene

Trade Name(s): Tace

Chemically Related To: Steroids

Pregnancy Category: X

Medical Category: Systemic estrogen, antineoplastic

Accepted Indications: Estrogen deficiency, atropic vaginitis, female hypogonadism, prostatic carcinoma, vulvar squamous hyperplasia, primary ovarian failure, symptoms of menopause

Unaccepted Indications: Reduction of postpartum breast engorgement

Mechanism of Action: Estrogen replacement and reduces release of gonadotropin–{endash}releasing hormone

Absorption/Distribution: Distributed to all tissues, especially fat; moderate protein binding

Metabolism: Hepatic, muscle, kidneys, gonads

Elimination: Renal, fecal

Research Notes: Chlorotrianisene has a long–{endash}lasting effect, interfering with cyclical therapy

Adult Dosage: 12–{endash}25 mg/d

Elderly Dosage: Same as adult dose

Dosage Forms: Capsules: 12 mg, 25 mg

By System: Hormonal

Warnings: Possible dental problems; do not share medication

Precautions: Stop medication if pregnancy suspected

Frequent Side Effects: Breast tenderness, gynecomastia, cramping

Occasional Side Effects: Diarrhea, headache, vomiting, migraine headache

Rare Side Effects: Amenorrhea, breast tumors, chorea, hepatitis, thromboembolism, altered menstrual cycle

Contraindications: Breast cancer, abnormal vaginal bleeding

Disease States: Endometriosis, liver and gallbladder problems, thrombophlebitis, jaundice

Other Drugs: Adrenocorticoids, bromocriptine, liver-damaging drugs, tamoxifen

Lab Tests: Fasting blood glucose, metyrapone, thyroid function, serum folate, calcium, clotting factors, glucose tolerance

Chloroxine

Trade Name(s): Capitrol

Chemically Related To: Unique compound

Pregnancy Category: C

Medical Category: Antiseborrheic

Accepted Indications: Dandruff, seborrheic dermatitis

Mechanism of Action: Slows mitotic action in skin

Research Notes: Onset of action 14 d

Adult Dosage: To scalp 2 times/w

Elderly Dosage: Same as adult dose

Dosage Forms: Lotion shampoo: 2%

By System: Topical

Warnings: Do not use on blistered or raw scalp; avoid eyes

Precautions: Possible discoloration of light-colored hair

Occasional Side Effects: Burning feeling on scalp, itching scalp

Rare Side Effects: Eye irritation

Disease States: Acutely inflamed lesions of scalp

Administrative Notes: Wet hair with warm water and lather for 3 min

Chlorphenesin Carbamate

Trade Name(s): Maolate

Chemically Related To: Meprobamate

Pregnancy Category: C

Medical Category: Skeletal muscle relaxant

Accepted Indications: Skeletal muscle spasm

Mechanism of Action: Reduces impulses from spinal cord to skeletal muscles

Absorption/Distribution: Rapid, complete absorption

Half life: 2.5–{endash}5 h

PO: 1.3 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Relationship between GI bleeding and chlorphenesin reported but not verified

Adult Dosage: 800 mg t.i.d.

Elderly Dosage: Same as adult dose

Dosage Forms: Tablets: 400 mg

Warnings: May cause drowsiness; avoid alcohol

Occasional Side Effects: Confusion, dizziness, drowsiness

Rare Side Effects: GI bleeding, agranulocytosis, leukopenia, thrombocytopenia, allergic dermatitis

Antidotal Therapy: May include saline cathartics or gastric lavage; supportive therapy

Disease States: CNS depression, liver and kidney problems

Other Drugs: CNS depressants

Administrative Notes: Drug use for more than 8 w not recommended

Chlorpheniramine Maleate

Trade Name(s): Aller-Chlor, Chlo-Amine, Chlor-Trimeton

Chemically Related To: Diphenhydramine

Pregnancy Category: B

Medical Category: Antihistaminic

Accepted Indications: Rhinitis, allergic conjunctivitis, pruritus, urticaria, angioedema, sneezing, anxiety

Mechanism of Action: Antihistamine

Absorption/Distribution: Well absorbed

Half life: 14–{endash}25 h

PO: 6 h

Metabolism: Hepatic, renal

Elimination: Renal

Research Notes: May inhibit lactation

Adult Dosage: 4 mg every 4–{endash}6 h

Elderly Dosage: More likely to have dizziness, sedation, and confusion

Child Dosage: Up to 6 y: not recommended; 6-12 y: 2 mg t.i.d. or q.i.d. up to 12 mg/d

Infant Dosage: Not recommended

Dosage Forms: Syrup: 1 mg/5 mL and 2 mg/5 mL; tablets: 4 mg; extended-release capsules: 8 mg and 12 mg; tablets (chewable): 2 mg; extended-release tablets: 8 mg and 12 mg; injection: 10 mg/mL and 100 mg/mL

By System: Systemic

Warnings: May cause drowsiness; avoid alcohol

Precautions: May mask ototoxic effects of salicylates

Frequent Side Effects: Drowsiness, thick mucus

Occasional Side Effects: Blurred vision, confusion, painful urination, dry mouth, tinnitus, stomach pain

Rare Side Effects: Blood dyscrasias, cardiac arrhythmias

Contraindications: Liver problems

Overdosage: Anticholinergic effects, cardiac arrhythmias, drowsiness, hallucinations, convulsions, hypotension

Antidotal Therapy: No specific antidote; may include emesis, gastric lavage, saline cathartics, vasopressors, IV fluids

Disease States: Bladder neck obstruction, prostatic hypertrophy, urinary retention, glaucoma

Other Drugs: Alcohol, anticholinergics, erythromycin, MAO inhibitors, ketoconazole, photosensitive medications

Lab Tests: Skin tests with allergen extracts

Administrative Notes: Take oral doses with food. 100-mg/mL solution for IM or SQ administration only

Chlorpheniramine Maleate/Codeine Phosphate/Guaifenesin

Trade Name(s): Tussar Sf, Tussar-2

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive, decongestant

Accepted Indications: Cough and cold

Dosage Forms: Syrup 6%/2 mg/10 mg/100 mg and 12%/2 mg/10 mg/100 mg

Chlorpheniramine Maleate/Codeine Phosphate/Phenylephrine Hydrochloride/Potassium Iodide

Trade Name(s): Pediacof, Pedituss

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive, antihistamine

Accepted Indications: Allergies, coughs, and colds

Child Dosage: 6 m–{endash}1 y: 1.25 mL; 1–{endash}3 y: 2.5–{endash}5 mL; 3–{endash}6 y: 5–{endash}10 mL; 6–{endash}12 y 10 mL every 4–{endash}6 h

Dosage Forms: Syrup: 0.75 mg/5 mg/2.5 mg/75 mg

Chlorpheniramine Maleate/Codeine Phosphate/Pseudoephedrine Hydrochloride

Trade Name(s): Alamine-C, Bayhistine DH, Codehist DH, Decohistine DH, Dihistine DH, Myhistine DH, Novahistine DH, Phenhist DH w/Codeine, Ryna-C Liquid

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive, antihistamine

Accepted Indications: Allergies, coughs, and colds

Adult Dosage: 10 mL every 4h

Child Dosage: 2–{endash}6 y: 1.25–{endash}2.5 mL q4h; 6–{endash}12 y: 2.5–{endash}5 mL q.i.d. q4h

Dosage Forms: Elixir 2 mg/10 mg/30 mg/5 mL; oral solution 2 mg/10 mg/30 mg

Chlorpheniramine Maleate/Guaifenesin/Phenylephrine Hydrochloride

Trade Name(s): Donatussin Drops (pediatric)

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Allergies, colds

Child Dosage: Under 3 m: 2–{endash}3 drops/m of age; 3–{endash}6 m: 0.3–{endash}0.6 mL; 6 m–{endash}1 y: 0.6–{endash}1 mL; 1–{endash}2 y: 1–{endash}2 mL every 4–{endash}6 h

Dosage Forms: Drops: 1 mg/20 mg/2 mg/mL

Chlorpheniramine Maleate/Methscopolamine Nitrate/Phenylephrine Hydrochloride

Trade Name(s): Ah-Chew, Dallergy, Extendryl, Histafed, Nasec, Rolatuss, Sinovan

Pregnancy Category: C

Medical Category: Antitussive, antihistamine

Accepted Indications: Allergies, coughs, and colds

Adult Dosage: Chewable tablet: 1–{endash}2 tablets q4h; syrup: 5–{endash}10 mL q4–{endash}6h; tablets: 1 q4–{endash}6h; extended-release tablets: 1 b.i.d.

Child Dosage: 6–{endash}12 y: chewable tablets 1 tablet q4h

Dosage Forms: Chewable tablets: 2 mg/1.25 mg/10 mg; syrup: 2 mg/0.625 mg/10 mg; tablets: 4 mg/1.25 mg/10 mg; extended-release caplets: 8 mg/2.5 mg/20 mg

Chlorpheniramine Maleate/Phenindamine Tartrate/Phenylpropanolamine Hydrochloride

Trade Name(s): Amilon Tr, Fenaclor, Nolamine, Norphenamine

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Coughs and colds

Adult Dosage: 1 tablet b.i.d. or t.i.d.

Dosage Forms: Tablets: 4 mg/24 mg/50 mg

Chlorpheniramine Maleate/Phenylephrine Hydrochloride/Phenylpropanolamine/Pyrilamine

Trade Name(s): Duohist Forte, Histalet Forte, Lantuss Forte, Poly Hist Forte, Prop-A-Hist, Vanex Forte

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Allergic rhinitis, allergic bronchitis, bronchospasm, hay fever, common cold, sinusitis, skin allergies

Adult Dosage: 1 tablet b.i.d. or t.i.d.

Child Dosage: Under 6 y: only as directed by physician; 6–{endash}12 y: ½ tablet b.i.d. or t.i.d.

Dosage Forms: Tablets: 4 mg/10 mg/50 mg/25 mg

Chlorpheniramine Maleate/Phenylpropanolamine Hydrochloride

Trade Name(s): Allerest 12-Hour Capsules, Condrin-LA, Contac Maximum Strength 12-Hour Caplets, Ornade Spansules, Ru-Tuss II Capsules

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Congestion, sneezing, rhinorrhea

Mechanism of Action: Competes with H1 receptors to prevent the histamine response; also acts on the mucous membrane of the respiratory tract to produce vasoconstriction, which reduces swelling

Absorption/Distribution: Well absorbed from GI tract

Half life: 21–{endash}27 h for chlorpheniramine; 3–{endash}4 for phenylpropanolamine

Peak activity: 2–{endash}6 h and 15–{endash}30 min

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: 1 capsule b.i.d.

Elderly Dosage: Same as adult dose

Child Dosage: Under 12 y: not recommended

Dosage Forms: Capsules 12 mg/75 mg

By System: Respiratory tract

Warnings: Administer b.i.d.; otherwise, tolerance develops

Precautions: In infants of breast-feeding mothers, patients at high risk from sympathomimetic agents

Frequent Side Effects: Drowsiness, thickening of bronchial secretions

Occasional Side Effects: Anticholinergic effects, palpitation, rash, stomach upset

Rare Side Effects: Blood dyscrasias, tachycardia, mood changes, tightness in chest

Overdosage: Anticholinergic effects, CNS stimulation, drowsiness, hypertension, extrapyramidal effects

Disease States: Bladder obstruction, urinary retention, cardiovascular disease, diabetes mellitus, hypertension, hyperthyroidism, prostatic hypertrophy

Other Drugs: Alcohol, CNS depressants or stimulants, anticholinergics, antidepressants, maprotiline, beta-adrenergic blocking agents, MAO inhibitors, rauwolfia alkaloids

Lab Tests: Skin tests with allergen extracts, glucose tolerance, immunologic urine pregnancy

Administrative Notes: Avoid alcoholic beverages; food, water, or milk should be taken to minimize gastric irritation

Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride

Trade Name(s): Anamine, Anamine T.D., Anaplex, Brexin-L.A., Chlorafed H.S., Chlorafed Timecelles, Chlordine H.R., Chlorphedrine HR, Codimal-L.A, Colfed-A, Cophene No. 2, Deconamine, Deconamine SR, Duralex, Dura-Tap PD, Fedahist Gyrocaps, Fedahist Timecaps, Histalet, Isoclor, Klerist-D, Kronofed-A Jr. Kronocaps, Kronofed-A Kronocaps, ND Clear T.D., Novafed A, Pseudo-Chlor, Rescon, Rescon-ED, Rescon JR, Rhinosyn, Rhinosyn PD, Rinade B.I.D., T-Dry Junior

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Allergies, colds

Adult Dosage: Varies by dosage form

Dosage Forms: Tablets: 4 mg/60 mg, 8 mg/120 mg; Syrup: 2 mg/12.5 mg, 2 mg/30 mg, 3 mg/45 mg; Oral solution: 2 mg/12.5 mg, 2 mg/30 mg, 4 mg/60 mg; Extended-release capsules: 4 mg/60 mg, 8 mg/120 mg, 10 mg/65 mg, 12 mg/120 mg; Capsules: 4 mg/60 mg

Chlorpheniramine Polistirex

Trade Name(s): Not available as a single agent

Medical Category: Antihistamine

Accepted Indications: Hypersensitivity reactions, including urticaria and angioedema, rhinitis, conjunctivitis, and pruritic skin disorders

Chlorpheniramine Polistirex/Hydrocodone Polistirex

Trade Name(s): Tussionex

Scheduled Class: III

Abuse Potential: Moderate

Pregnancy Category: C

Medical Category: Antitussive, antihistamine

Accepted Indications: Cough and upper respiratory symptoms associated with allergy or cold

Adult Dosage: 5 mL b.i.d.; do not exceed 10 mL in 24 h

Child Dosage: Under 6 y: not recommended; 6–{endash}12 y: 2.5 mL b.i.d., not to exceed 5 mL in 24 h

Infant Dosage: Not recommended

Dosage Forms: Oral suspension: 8 mg/10 mg per 5 mL

Chlorpheniramine Tannate

Trade Name(s): Not available as a single agent

Medical Category: Antihistamine

Accepted Indications: Hypersensitivity reactions, including urticaria and angioedema, rhinitis, conjunctivitis, and pruritic skin disorders

Chlorpheniramine Tannate/Phenylephrine Tannate/Pyrilamine Tannate

Trade Name(s): Equitan, Histatan, Rynatan, Tanoral, Tri-Tannate, Tritan

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Allergies, colds

Adult Dosage: 1–{endash}2 tablets b.i.d.

Child Dosage: Under 2 y, suspension: titrate dose individually; 2–{endash}6 y, suspension: 2.5–{endash}5 mL; over 6 y, suspension: 5–{endash}10 mL b.i.d.

Dosage Forms: Suspension: 2 mg/5 mg/12.5 mg; tablets: 8 mg/25 mg/25 mg

Chlorpheniramine/Phenylpropanolamine

Trade Name(s): Ornade Spansule

Chemically Related To: Antihistamines and decongestants

Pregnancy Category: C

Medical Category: Antihistaminic-decongestant

Accepted Indications: Congestion, sneezing, rhinorrhea

Mechanism of Action: Competes with H1-receptors to prevent the histamine response. Also acts on the mucous membrane of the respiratory tract to produce vasoconstriction which reduces swelling.

Absorption/Distribution: Well absorbed from GI tract

Half life: 14-25 h for chlorpheniramine and 3-4 h for phenylpropanolamine

Peak activity: 2-6 h/15-30 min

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: 1 capsule q 12 h

Elderly Dosage: Same as adult dose

Dosage Forms: Capsules

By System: Respiratory tract

Warnings: Keep within every 12 h or tolerance develops

Precautions: Mothers breast feeding should be aware that there is a high risk for infants from sympathomimetic agents

Frequent Side Effects: Drowsiness, thickening of bronchial secretions

Occasional Side Effects: Anticholinergic effects, pounding heartbeat, skin rash, stomach upset

Rare Side Effects: Blood dyscrasias, fast heartbeat, mood changes, tightness in chest

Overdosage: Anticholinergic effects, CNS stimulation, drowsiness, hypertension, extrapyramidal effects

Disease States: Bladder neck obstruction, urinary retention, cardiovascular disease, diabetes mellitus, hypertension, hyperthyroidism, prostatic hypertrophy

Other Drugs: Alcohol, CNS depression–{endash}producing medications, anticholinergics, antidepressants, maprotiline, beta-adrenergic blocking agents, CNS stimulation–{endash}producing medications, MOA inhibitors, rauwolfia alkaloids

Lab Tests: Skin tests using allergen extracts, glucose tolerance tests and immunologic urine pregnancy tests

Administrative Notes: Avoid alcoholic beverages. Food, water, or milk should be taken to minimize gastric irritation.

Chlorpromazine Hydrochloride

Trade Name(s): Thorazine

Chemically Related To: Phenothiazines

Pregnancy Category: Sufficient studies not done; potential for embryotoxicity

Medical Category: Antipsychotic, antiemetic, antidyskinetic

Accepted Indications: Psychotic disorders, nausea and vomiting, tetanus adjunctive management, acute porphyria, intractable hiccups, Huntington's disease

Mechanism of Action: Blocks dopamine receptors

PO: 4–{endash}7 d

IM: 24 h

Metabolism: Hepatic

Elimination: Renal, biliary

Research Notes: Onset of action as an antipsychotic takes several weeks

Adult Dosage: 10–{endash}50 mg t.i.d. or q.i.d. up to 1 g/d

Elderly Dosage: Require lower initial dosage

Child Dosage: Over 6 m: 550 m{mu}g/kg every 4–{endash}6 h

Infant Dosage: Up to 6 m: dosage not established

Dosage Forms: Extended-release capsules: 30 mg, 75 mg, 150 mg, 200 mg, and 300 mg; oral concentrate: 30 mg/mL and 100 mg/mL; syrup: 10 mg/mL; tablets: 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg; injection USP: 25 mg/mL; suppositories 25 mg and 100 mg

By System: CNS, subcortical nuclei

Warnings: May cause drowsiness; avoid alcohol

Precautions: Caution if surgery required; caution during exercise or hot weather

Frequent Side Effects: Akathisia, hypotension, anticholinergic effects, tardive dyskinesia

Occasional Side Effects: Changes in menstrual period, weight gain, dizziness, nausea and vomiting, trembling upper extremities, photosensitivity

Rare Side Effects: Agranulocytosis, heat stroke, melanosis, neuroleptic malignant syndrome, hepatitis

Contraindications: Cardiovascular problems, CNS depression, coma

Antidotal Therapy: Symptomatic and supportive treatment; may include gastric lavage, activated charcoal slurry, saline cathartics

Disease States: Blood dyscrasias, glaucoma, liver problems, Reye's syndrome, peptic ulcer, vomiting, convulsions, breast cancer

Other Drugs: CNS depressants, antithyroid agents, epinephrine, levodopa, antihypertensives, lithium, anticonvulsants, narcotics

Lab Tests: Bilirubin, EKG, metyrapone, immunologic urine pregnancy, gonadorelin

Administrative Notes: More riboflavin may be required in diet

Chlorpropamide

Trade Name(s): Diabinese, Glucamide

Chemically Related To: Sulfonylureas

Pregnancy Category: C

Medical Category: Antidiabetic agent

Accepted Indications: Diabetes mellitus, neurogenic diabetes insipidus

Mechanism of Action: Stimulates insulin release from pancreatic beta cells

Absorption/Distribution: Readily absorbed from GI tract; high protein binding

Half life: 36 h

PO: 2–{endash}4 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Approximately 6 times as potent as tolbutamide; isoluble in water; soluble in alcohol

Adult Dosage: 250 mg/d

Elderly Dosage: 100–{endash}125 mg/d

Dosage Forms: Tablets: 100 mg and 250 mg

By System: Hormonal

Warnings: Must follow weight control, proper exercise, and hygiene; avoid infection

Precautions: During first 6 w, patient should be evaluated weekly; frequent tests of hepatic function

Occasional Side Effects: Edema

Rare Side Effects: Photosensitivity reactions

Contraindications: Major surgery, severe trauma, severe infections

Disease States: Hepatic porphyria; kidney, liver or thyroid problems; Addison's disease; pituitary insufficiency

Nutrition: Dietary regulation important

Other Drugs: Alcohol, anticoagulants, thiazide diuretics, salicylates, sulfonamides, miconazole, fluconazole, barbiturates

Administrative Notes: Hospitalization possibly needed to change patient from higher dosages of insulin to chlorpropamide

Chlorprothixene

Trade Name(s): Tarasan

Chemically Related To: Tricyclic antidepressants

Pregnancy Category: C

Medical Category: Antipsychotic

Accepted Indications: Psychotic disorders

Mechanism of Action: Blocks dopamine receptors in brain

Absorption/Distribution: Partially absorbed

Half life: 2–{endash}4 h

PO: 2 h

IM: 30 min; 12 h duration

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: Usual dose 25–{endash}50 mg 3 or 4 times/d up to 600 mg/d

Elderly Dosage: Decrease dose

Child Dosage: 6–{endash}12 y: up to 40 mg/d

Dosage Forms: Tablets: 10 mg, 25 mg, 50 mg, and 100 mg; injection: 12.5 mg/mL

By System: CNS

Warnings: May cause drowsiness; avoid alcohol

Precautions: Regular visits to physician recommended; avoid antacids

Frequent Side Effects: Akathisia, tardive dyskinesia, constipation, dry mouth, nasal congestion

Occasional Side Effects: Anticholinergic effect, skin discoloration, decreased sexual ability, hypotension

Rare Side Effects: Agranulocytosis, heat stroke, liver dysfunction, neuroleptic malignant syndrome

Contraindications: Blood dyscrasias, bone marrow depression, circulatory collapse, CNS depression, coma

Overdosage: Convulsions, difficulty in breathing, dizziness, hypotension, coma

Antidotal Therapy: May include gastric lavage or emesis, activated charcoal slurry, saline cathartics, IV phenytoin, maintenance of respiratory function

Disease States: Alcoholism, heart disease, liver and respiratory problems, convulsions, urinary retention

Other Drugs: CNS depressants, amphetamines, epinephrine, levodopa, quinidine, MAO inhibitors, antihistamines

Lab Tests: EKG readings (prolongs QT interval), urine bilirubin, immunologic urine pregnancy, serum uric acid concentration

Administrative Notes: Avoid skin contact with liquid form of this medication; stains skin

Chlorthalidone

Trade Name(s): Hygroton, Thalitone

Chemically Related To: Thiazides

Pregnancy Category: B

Medical Category: Diuretic, antihypertensive, antidiuretic (diabetes insipidus), antiurolithic

Accepted Indications: Edema, hypertension, diabetes insipidus, renal calculi (prophylaxis)

Mechanism of Action: Inhibits sodium reabsorption

Absorption/Distribution: Rapid absorption

Half life: 35–{endash}50 h

PO: Onset of action 2 h; duration of action 48–{endash}72 h

Elimination: Renal

Adult Dosage: 25–{endash}100 mg once daily

Elderly Dosage: Caution required

Child Dosage: 2 mg/kg once daily 3 d/w

Infant Dosage: Caution in jaundiced infants, increased risk of hyperbilirubinemia from USPD

Dosage Forms: Tablets: 25 mg, 50 mg, and 100 mg

By System: Cardiovascular

Warnings: May cause photosensitivity; do not take other medications without physician's advice

Precautions: Continue medicine even if symptoms disappear

Frequent Side Effects: Electrolyte imbalance (hypokalemia, hyponatremia)

Occasional Side Effects: Anorexia, diarrhea, photosensitivity, GI upset

Rare Side Effects: Agranulocytosis, allergic reactions, gout, liver problems, thrombocytopenia, hyperglycemia

Contraindications: History of gout or lupus erythematosus

Antidotal Therapy: May include emesis/gastric lavage, supportive treatment, monitoring of serum electrolytes and kidney function

Disease States: Diabetes mellitus, gout, anuria, hypercalcemia, pancreatitis, lupus erythematosus, jaundice

Nutrition: Sodium restriction

Other Drugs: Digitalis glycosides, cholestyramine, anticoagulants, lithium, neuromuscular blocking agents

Lab Tests: Bilirubin, glucose (blood and urine), uric acid, urinary calcium concentrations, protein-bound iodine, phentolamine, tyramine

Chlorthalidone/Clonidine Hydrochloride

Trade Name(s): Clonidine HCL with chlorthalidone, Clorodone, Combipres

Pregnancy Category: C

Medical Category: Antihypertensive

Accepted Indications: Hypertension

Adult Dosage: Must be titrated individually

Dosage Forms: Tablets: 15 mg/0.1 mg, 15 mg/0.2 mg, 15 mg/0.3 mg

Chlorthalidone/Reserpine

Trade Name(s): Demi-Regroton, Regroton

Pregnancy Category: C

Medical Category: Antihypertensive

Accepted Indications: Hypertension

Adult Dosage: Must be titrated individually

Dosage Forms: Tablets: 25 mg/0.125 mg and 50 mg/0.25 mg

Chlorzoxazone

Trade Name(s): Paraflex, Parafon Forte DSC

Medical Category: Skeletal muscle relaxant

Accepted Indications: Skeletal muscle spasm

Mechanism of Action: Depresses polysynaptic reflexes in CNS

Absorption/Distribution: Rapid, complete absorption

Half life: 1–{endash}2 h

PO: 1–{endash}2 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Onset of action, 1 h; duration of action, 3–{endash}4 h

Adult Dosage: 250–{endash}750 mg t.i.d. or q.i.d.

Elderly Dosage: Use with caution

Child Dosage: 20 mg/kg in 3–{endash}4 divided doses

Infant Dosage: Same as child dose

Dosage Forms: Tablets: 250 mg and 500 mg

By System: CNS, subcortical nuclei

Warnings: May cause drowsiness; avoid alcohol

Precautions: May color urine orange

Frequent Side Effects: Dizziness, drowsiness

Occasional Side Effects: Headache

Rare Side Effects: GI bleeding, anemia, yellowing of skin

Antidotal Therapy: May include emesis/gastric lavage, oxygen, plasma volume expanders

Disease States: Allergies, CNS depression, liver and kidney problems

Other Drugs: CNS depressants

Administrative Notes: May be crushed and mixed with food

Cholestyramine

Trade Name(s): Cholybar, Questran

Chemically Related To: Polymer resin; anion-exchange resin

Pregnancy Category: C

Medical Category: Antihyperlipidemic, antipruritic, antidiarrheal, antidote, antihyperoxaluric

Accepted Indications: Hyperlipidemia, pruritus or diarrhea caused by bile acids, hyperoxaluria, digitalis glycoside overdose

Absorption/Distribution: Not absorbed from GI tract

Metabolism: Absorbs bile acids in the intestine

Elimination: Fecal

Research Notes: Onset of action 24–{endash}48 h and blood lipid level may continue to fall for 1 y

Adult Dosage: Up to 32 g/d

Elderly Dosage: Over 60 y: more GI side effects

Child Dosage: 6–{endash}12 y: oral 80 mg/kg t.i.d.; under 6 y: not established

Dosage Forms: Chewable bars: 4 g; for oral suspension: 5 g and 9 g

By System: Local, intestine only

Precautions: Mix oral suspension with fluid before taking

Frequent Side Effects: Constipation

Occasional Side Effects: Belching, bloating, diarrhea, dizziness, headache

Rare Side Effects: Gallstones, GI bleeding, peptic ulcer, malabsorption syndrome

Disease States: Bleeding disorders, gallstones, constipation, peptic ulcer, kidney problems, hypothyroidism, hemorrhoids

Other Drugs: Anticoagulants, diuretics, tetracyclines, folic acid, thyroid hormones, fat-soluble vitamins

Lab Tests: Prothrombin time; potassium, sodium, phosphorus, and calcium concentrations; alkaline phosphatase; Schilling test; fat-soluble vitamins

Administrative Notes: Variations in color normal and do not indicate change in strength of product. Proper diet required

Choline Bitartrate

Chemically Related To: Vitamin B

Pregnancy Category: B

Medical Category: GI drugs; vitamins/minerals

Accepted Indications: Possibly effective–{endash}tardive dyskinesia, Huntington's chorea, Tourette's syndrome, Freidreich's ataxia, presenile dementia, fatty liver, cirrhosis

Mechanism of Action: Enhances cholinergic effects of acetylcholine

Research Notes: Fish, peanuts, beef liver, eggs and wheat germ are rich in choline

Adult Dosage: 650 mg–{endash}2 g/d or as directed

Dosage Forms: Tablets: 250 mg

Choline Salicylate

Trade Name(s): Arthropan

Chemically Related To: Acetylsalicylic acid

Pregnancy Category: Avoid use during pregnancy

Medical Category: Analgesic, anti-inflammatory, antipyretic, antirheumatic

Accepted Indications: Pain, fever, arthritis, inflammation, osteoarthritis, rheumatic fever

Mechanism of Action: Inhibits activity of cyclo-oxygenase

Absorption/Distribution: Rapid and complete

Half life: Dose dependent

PO: 1–{endash}2 h

Metabolism: GI tract, liver, blood

Elimination: Renal

Adult Dosage: 870–{endash}1338 mg q.i.d. as needed

Elderly Dosage: Lower dose may be required

Child Dosage: Varies by age

Infant Dosage: Must be individualized

Dosage Forms: Oral solution: 870 mg/5 mL

Frequent Side Effects: GI irritation

Occasional Side Effects: Anemia, allergic dermatitis, anaphylaxis, GI ulceration, troubled breathing

Contraindications: Bleeding ulcers, hemophilia

Overdosage: Ringing, buzzing in ears, confusion, fast or deep breathing

Antidotal Therapy: May include emesis, activated charcoal

Disease States: Gout, peptic ulcer, gastritis, hemorrhagic states, renal insufficiency

Other Drugs: Anticoagulants, insulin, verapamil, vancomycin, acetaminophen, NSAIDs, heparin, thrombolytic agents, antidiabetic agents, cefamandole, cefotetan, plicamycin, cefoperazone, moxalactam disodium, valproic acid, sulfinpyrazone, ketoconazole, tetracyclines, probenecid, methotrexate, urinary alkalizers

Lab Tests: Gerhardt test, thyroid imaging

Choline Salicylate/Magnesium Salicylate

Trade Name(s): Trilisate, Tricosal

Chemically Related To: Salicylates

Pregnancy Category: C

Medical Category: Analgesic, anti-inflammatory, antipyretic, antirheumatic

Accepted Indications: Rheumatoid arthritis, acute pain in shoulder, pain, fever, inflammation, osteoarthritis, rheumatic fever

Mechanism of Action: Inhibits prostaglandin synthesis

Absorption/Distribution: Rapid and complete absorption

Half life: 2–{endash}3 h

PO: 2 h

Metabolism: GI tract, liver, blood

Elimination: Renal

Research Notes: Often called choline and magnesium salicylate in drug monographs

Adult Dosage: 2–{endash}3 g/d in 2–{endash}3 doses

Elderly Dosage: Lower doses recommended

Child Dosage: More than 37 kg: 2.2 g/d in 2 divided doses

Infant Dosage: Up to 37 kg: 50 mg/kg/d in 2 doses

Dosage Forms: Oral solution 293 mg/362 mg; tablets: 293 mg/362 mg, 440 mg/544 mg, and 587 mg/725 mg

By System: CNS

Warnings: Do not take tetracyclines within 1–{endash}2 h of this drug

Precautions: Use caution if surgery required

Frequent Side Effects: GI irritation

Occasional Side Effects: Anemia, GI ulceration

Rare Side Effects: Allergic dermatitis, shortness of breath, angioedema

Contraindications: Bleeding ulcers, hemorrhage, hemophilia, advanced kidney problems

Overdosage: CNS disturbances, alteration in electrolytes, respiratory and metabolic acidosis, hyperthermia, dehydration

Antidotal Therapy: May include emesis/gastric lavage, activated charcoal, monitoring of electrolytes, alkaline diuresis, Vitamin K if necessary

Disease States: Gastritis, peptic ulcer, renal function impairment, gout, hypertension, anemia

Other Drugs: Vancomycin, probenecid, methotrexate, zidovudine, anticoagulants, NSAIDs, urinary alkalizers

Lab Tests: Liver function, prothrombin time, serum cholesterol concentrations, copper sulfate, urine glucose, vanillylmandelic acid

Administrative Notes: Each 500-mg tablet same as 650 mg of aspirin in salicylate content

Ciclopirox Olamine

Trade Name(s): Loprox

Chemically Related To: Imidazoles

Pregnancy Category: B

Medical Category: Topical antifungal

Accepted Indications: Cutaneous candidiasis, tinea corporis, tinea cruris, tinea pedis, tinea versicolor, and onychomycosis

Mechanism of Action: Fungicidal; interferes with synthesis of protein, DNA, and RNA

Absorption/Distribution: Rapid, incomplete absorption

Half life: 1.7 h

Elimination: Renal

Research Notes: Penetrates into hair, sebaceous glands, dermis

Adult Dosage: To skin b.i.d., morning and night

Elderly Dosage: Same as adult dose

Child Dosage: Over 10 y: same as adult dose

Dosage Forms: Cream: 1%; lotion: 1%

By System: Dermal

Warnings: Avoid eyes; do not apply occlusive dressings

Rare Side Effects: Local irritation

Administrative Notes: Shake lotion well

Cilastatin Sodium

Trade Name(s): Not available as a single agent

Pregnancy Category: C

Medical Category: Beta-lactamase inhibitor

Mechanism of Action: Inhibits renal dipeptidase dehydropeptidase; blocks renal metabolism of imipenem and increases its urinary recovery

Absorption/Distribution: 75% absorption; moderate protein binding

Half life: 1 h (normal renal function), 13.3–{endash}17.1 h (impaired renal function)

IM: 1 h

Cilastatin Sodium/Imipenem

Trade Name(s): Primaxin I.M, Primaxin I.V.

Pregnancy Category: C

Medical Category: Antibacterial

Accepted Indications: Bone and joint infections, bacterial endocarditis, intra-abdominal infections, pelvic infections, bacterial pneumonia, bacterial septicemia, skin and soft tissue infections, bacterial urinary tract infections

Adult Dosage: Varies by type and severity of infection and degree of renal function

Elderly Dosage: May require lower dosage

Child Dosage: Weight <40>

Dosage Forms: For injection: 250 mg/250 mg and 500 mg/500 mg; for suspension: 500 mg/500 mg and 750 mg/750 mg

Cimetidine

Trade Name(s): Tagamet

Chemically Related To: Antihistamine (H2-receptor antagonist)

Pregnancy Category: B

Medical Category: Histamine H2-receptor antagonist, antiulcer agent, gastric acid secretion inhibitor, urticaria therapy agent

Accepted Indications: Duodenal ulcer, gastric ulcer, gastric hypersecretory conditions, Zollinger-Ellison syndrome, systemic mastocytosis, upper GI bleeding, acute urticaria

Unaccepted Indications: Minor digestive complaints

Mechanism of Action: Inhibits gastric acid secretion through inhibition of histamine

Absorption/Distribution: Rapid absorption; distributed in CSF

Half life: 2 h

PO: 1–{endash}2 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Duration of action: nocturnal 6–{endash}8 h; basal 4–{endash}5 h

Adult Dosage: Up to 2.4 g/d. Usual treatment of peptic ulcer: 800 mg/d

Elderly Dosage: Same as adult dose

Child Dosage: For gastric ulcer, 20–{endash}40 mg/kg/d in 4 doses

Infant Dosage: Consider risk-benefit ratio

Dosage Forms: Tablets: 200 mg, 300 mg, 400 mg, and 800 mg; oral solution: 300 mg/5 mL; injection: 300 mg/2 mL and 300 mg/50 mL

By System: GI

Warnings: Avoid alcohol

Precautions: Discontinue smoking

Occasional Side Effects: Diarrhea, dizziness, drowsiness

Rare Side Effects: Agranulocytosis, bradycardia, confusion, fever, gynecomastia, myopathy

Antidotal Therapy: No specific antidote; may include emesis/gastric lavage, IV diazepam, atropine, lidocaine

Disease States: Cirrhosis, liver and kidney problems

Nutrition: Foods that cause GI irritation

Other Drugs: Opioid analgesics, antiarrhythmics, antacids, bone marrow depressants, ketoconazole, alcohol, anticoagulants, tricyclic antidepressants, xanthines, antiepileptics, theophylline

Lab Tests: Gastric acid secretion, skin tests with allergen extracts, prolactin, parathyroid hormone, creatinine

Cinoxacin

Trade Name(s): Cinobac

Chemically Related To: Quinolones

Pregnancy Category: C

Medical Category: Systemic antibacterial

Accepted Indications: Urinary tract infections

Unaccepted Indications: Infections caused by Pseudomonas species, Enterococcus faecalis, staphylococci

Mechanism of Action: Bactericidal; inhibits DNA replication

Absorption/Distribution: Rapidly and completely absorbed; moderate to high protein binding

Half life: 1.5–{endash}2 h

PO: 2–{endash}3 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: With kidney problems half-life possibly exceeds 10 h

Adult Dosage: 250 mg q.i.d. or 500 mg b.i.d. for 7–{endash}14 d

Elderly Dosage: Kidney problems necessitate lower dose

Child Dosage: Not recommended

Infant Dosage: Not recommended

Dosage Forms: Capsules: 250 mg and 500 mg

Occasional Side Effects: GI problems

Rare Side Effects: Dizziness, headache

Disease States: Kidney problems, rash, hypersensitivity

Lab Tests: BUN, serum creatinine, alanine aminotransferase, alkaline phosphatase

Ciprofloxacin Hydrochloride

Trade Name(s): Cipro

Chemically Related To: Oxyquinolines

Pregnancy Category: C

Medical Category: Antibacterial

Accepted Indications: Bone, skin and soft tissue, and urinary tract infections; gram-negative bacterial pneumonia; bacterial diarrhea

Unaccepted Indications: Infections caused by Pseudomonas cepacia and Pseudomonas maltophilia

Mechanism of Action: Inhibits DNA gyrase; promotes bacterial double-stranded DNA breakage

Absorption/Distribution: Well absorbed; distributed in all body tissues

Half life: PO, 4 h; IV, 5–{endash}6 h

Peak activity: 1–{endash}2 h

PO: 1–{endash}2 h

IV: Immediate

Metabolism: Hepatic

Elimination: Renal, fecal

Research Notes: Moderately effective against streptococci

Adult Dosage: Tablets 250–{endash}750 mg b.i.d.; IV 200–{endash}400 mg b.i.d.

Elderly Dosage: Dosage reduction may be required

Child Dosage: Not recommended

Infant Dosage: Not recommended

Dosage Forms: Tablets: 250 mg, 500 mg, and 750 mg; injection: 200 mg/20 mL and 400 mg/40 ml; for injection: 200 mg/100 mL and 400 mg/200 mL

Frequent Side Effects: GI distress, slight nausea and vomiting, dizziness, headache, drowsiness

Occasional Side Effects: Cramps, diarrhea

Rare Side Effects: CNS stimulation, hypersensitivity, interstitial nephritis, phlebitis, hepatitis, tendinitis

Contraindications: Allergy to fluoroquinolones or other quinolone derivatives

Disease States: CNS disorders, renal impairment, alcoholism

Other Drugs: Antacids, sucralfate, theophylline, warfarin, NSAIDs, cyclosporine

Lab Tests: BUN, bilirubin, creatinine concentrations

Administrative Notes: Take on empty stomach

Cisplatin

Trade Name(s): Platinol

Chemically Related To: Unique compound

Pregnancy Category: D

Medical Category: Antineoplastic

Accepted Indications: Carcinomas, neuroblastomas, germ cell tumors, osteosarcomas

Mechanism of Action: Interferes with DNA and RNA, leading to cancer cell death

Absorption/Distribution: Does not cross blood–{endash}brain barrier

Half life: Alpha phase, 25–{endash}49 min; beta phase, 58–{endash}73 h

Metabolism: Nonenzymatic conversion

Elimination: Renal

Research Notes: Cell cycle nonspecific

Adult Dosage: Varies by patient and indication. Dose range 20–{endash}100 mg/m2

Elderly Dosage: Dosage reduction may be required

Dosage Forms: Injection 1 mg/mL; for injection 10 mg, 50 mg, and 100 mg

By System: Rapidly growing tissue

Warnings: Avoid immunizations; ototoxic effects may be more severe in children

Precautions: Continue medication even if GI distress occurs

Frequent Side Effects: Leukopenia, thrombocytopenia, nephrotoxicity, nausea, vomiting

Occasional Side Effects: Anaphylactic reaction, neurotoxicity, loss of appetite

Rare Side Effects: Cerebral blindness, dizziness, confusion, optic neuritis

Disease States: Bone marrow depression, chickenpox, gout, infection, kidney or liver problems, hearing difficulties

Other Drugs: Nephrotoxic or ototoxic medications, live virus vaccines, probenecid, bone marrow depressants

Lab Tests: BUN, serum uric acid, Coombs' test, creatinine clearance, serum phosphate and potassium concentrations

Administrative Notes: Need ample fluid intake

Clarithromycin

Trade Name(s): Biaxin

Chemically Related To: Erythromycin

Pregnancy Category: C

Medical Category: Systemic antibacterial

Accepted Indications: Bronchitis (bacterial), pharyngitis (streptococcal), pneumonia (caused by Mycoplasma and Streptococcus), sinusitis, skin and soft tissue infections, legionnaires' disease

Mechanism of Action: Inhibits protein synthesis

Absorption/Distribution: Well absorbed; widely distributed

Half life: 3–{endash}4 h

PO: 2 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Detected in human breast milk

Adult Dosage: 250–{endash}500 mg b.i.d. for 7–{endash}14 d

Elderly Dosage: In renal deficiency, decrease dose

Dosage Forms: Tablets: 250 mg and 500 mg

Occasional Side Effects: Abnormal taste, GI distress, headache

Disease States: Kidney problems

Other Drugs: Carbamazepine, theophylline, zidovudine, terfenadine, rifabutin, astemizole, midazolam

Lab Tests: BUN, alanine aminotransferase, aspartate aminotransferase

Clavulanate Potassium

Trade Name(s): Not available as a single agent

Chemically Related To: Penicillins

Medical Category: Beta-lactamase inhibitor

Mechanism of Action: Inactivates beta-lactamase enzymes

Half life: 1 h (normal renal function), 3 h (impaired renal function)

Research Notes: Used in combination with amoxicillin and ticarcillin disodium; has little antibacterial activity when used alone

Clavulanate Potassium/Ticarcillin Disodium

Trade Name(s): Timentin

Pregnancy Category: B

Medical Category: Systemic antibacterial

Accepted Indications: Bacterial pneumonia, bacterial septicemia, bone and joint infections, intra-abdominal infections, pelvic infections, skin and soft tissue infections, urinary tract infections

Adult Dosage: Antibacterial: up to 60 kg; IV infusion, 1.1–{endash}1.7 mg/33.3–{endash}50 mg/kg q4h or 1.7–{endash}2.5 mg/50–{endash}75 mg/kg q.i.d.; 60 kg and over: IV infusion, 100 mg/3 g q4–{endash}6h; surgical prophylaxis: IV infusion, 100 mg/3 g 0.5–{endash}1 h before surgery, then 3.1 g q4h for a total of 3 doses

Elderly Dosage: Lower dosage may be required

Child Dosage: 1 m–{endash}12 y: IV infusion, 1.7 mg/50 mg/kg q4–{endash}6h; over 12 y: same as adult dose

Infant Dosage: Under 1 m: not established; 1 m–{endash}12 y: IV infusion, 1.7 mg/50 mg/kg q4–{endash}6h

Dosage Forms: Sterile injection: 3.1 g (100 mg/3 g) and 31 g (1 g/30 g)

Clemastine Fumarate

Trade Name(s): Contac 12 Hour Allergy, Tavist, Tavist-1

Chemically Related To: Ethanolamine

Pregnancy Category: C

Medical Category: Antihistamine (H1-receptor blocker)

Accepted Indications: Rhinitis, allergic conjunctivitis, pruritus, urticaria, angioedema, transfusion reactions, sneezing, rhinorrhea, anaphylactic reaction

Mechanism of Action: Competes with histamine for H1 receptor site

Absorption/Distribution: Well absorbed

PO: 5–{endash}7 h

Metabolism: Hepatic, some renal

Elimination: Renal

Research Notes: Duration of action 12 h

Adult Dosage: 1.34 mg b.i.d. or 2.68 mg once daily to t.i.d., up to 8.04 mg/d

Elderly Dosage: More chance of dizziness, sedation, confusion, and hypotension

Child Dosage: Under to 6 y: dosage not established; 6–{endash}12 y: 670 m{mu}g–{endash}1.34 mg b.i.d.

Infant Dosage: Not recommended in premature or newborn infants

Dosage Forms: Syrup: 0.67 mg/5 mL; tablets: 1.34 mg and 2.68 mg

Warnings: Avoid alcohol, drowsiness

Precautions: Possible dry mouth, so use sugarless gum or candy; drug could mask ototoxic effects of salicylates

Frequent Side Effects: Drowsiness, thick mucus

Occasional Side Effects: Blood dyscrasias, cardiac arrhythmias

Rare Side Effects: Blurred vision, confusion, dizziness, appetite loss, buzzing in ears

Contraindications: Liver problems

Overdosage: Anticholinergic effects, cardiac arrhythmias, drowsiness, hallucinations, convulsions, low blood pressure

Antidotal Therapy: No specific antidote; may include emesis/gastric lavage, saline cathartics, vasopressors, oxygen, and IV fluids

Disease States: Glaucoma, urinary retention, bladder neck obstruction

Nutrition: Take with food or water

Other Drugs: Alcohol, anticholinergics, MAO inhibitors, ototoxic medications, photosensitizing medications, erythromycin

Lab Tests: Skin tests using allergen extracts

Administrative Notes: Store tablets in a tight light-resistant container

Clemastine Fumarate/Phenylpropanolamine Hydrochloride

Trade Name(s): Tavist-D

Pregnancy Category: C

Medical Category: Antihistamine, decongestant

Accepted Indications: Allergies, colds

Adult Dosage: 1 tablet b.i.d.

Child Dosage: Consult physician

Dosage Forms: Tablets: 1.34 mg/75 mg

Clidinium Bromide

Trade Name(s): Quarzan

Chemically Related To: Atropine

Pregnancy Category: C

Medical Category: Anticholinergic

Accepted Indications: Peptic ulcer

Mechanism of Action: Acetylcholine blocker

Absorption/Distribution: Irregular absorption; little distribution past blood-brain barrier

Metabolism: Hepatic

Elimination: Renal/fecal

Research Notes: Onset of action, 1 h; duration of action, up to 3 h

Adult Dosage: 2.5–{endash}5 mg 3–{endash}4 times/d with meals and at bedtime

Elderly Dosage: 2.5 mg t.i.d.

Child Dosage: Not established

Dosage Forms: Capsules: 2.5 mg and 5 mg

By System: Parasympathetic

Warnings: Blurred vision; photosensitivity

Precautions: Overheating may result in heat stroke; possible dizziness

Frequent Side Effects: Constipation, decreased sweating, dry mouth

Occasional Side Effects: Decreased flow of breast milk, difficulty with urination

Rare Side Effects: Bloated feeling, headache, memory loss, tiredness

Overdosage: Blurred vision, clumsiness, confusion, difficulty in breathing, dizziness, tachycardia, fever, hallucinations, convulsions

Antidotal Therapy: May include emesis or gastric lavage, slurry of activated charcoal, slow IV physostigmine, short-acting barbiturates, infusion of norepinephrine, oxygen

Disease States: Brain damage in children, cardiac disease, glaucoma, myasthenia gravis, tachycardia, ulcerative colitis

Other Drugs: Narcotics, ketoconazole, haloperidol, anticholinergics, antimyasthenics, urinary alkalizers

Lab Tests: Gastric acid secretion

Administrative Notes: Store in a tight, light-proof container

Clindamycin

Trade Name(s): Cleocin, Cleocin T, Clinda-Derm

Chemically Related To: Macrolide antibiotics

Pregnancy Category: Problems have not been documented

Medical Category: Antibacterial, antiprotozoal, antiacne agent, anti-infective

Accepted Indications: Bone, joint, pelvic, intra-abdominal, or skin and soft tissue infections; pneumonia; septicemia; acne vulgaris; bacterial vaginosis

Unaccepted Indications: Meningitis, deep cystic lesions; infections caused by Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and Candida albicans; herpes simplex

Mechanism of Action: Binds to 50S ribosome subunits and prevents peptide bond formation

Absorption/Distribution: PO and injection: well absorbed; distributed to all body tissues. Topical and vaginal: 2%–{endash}8% absorbed

Half life: 2.4–{endash}3 h (PO and injection); 1.5–{endash}2.6 h (vaginal)

Peak activity: 16 h (vaginal)

PO: 1 h

IV: 1 h

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: Varies by indication and form

Elderly Dosage: Varies by indication and form

Child Dosage: Varies by indication and form

Infant Dosage: Varies by indication and form

Dosage Forms: Capsules: 75 mg, 150 mg, and 300 mg; for oral solution: 75 mg/5 mL; injection: 300 mg/2 mL, 600 mg/4 mL, and 900 mg/6 mL; gel: 1%; topical solution: 1%; topical suspension: 1%; vaginal cream: 2%

Frequent Side Effects: Pseudomembranous colitis, nausea and vomiting, itching of rectal and genital areas, dryness or peeling of skin

Occasional Side Effects: Stomach cramps, diarrhea, fever, sore throat, hypersensitivity, thromocytopenia, burning sensation in skin

Rare Side Effects: Rash

Disease States: GI disease, hepatic or renal function impairment, colitis

Other Drugs: Antidiarrheals, hydrocarbon inhalation anesthetics, chloramphenicol, erythromycins, neuromuscular blocking agents, abrasive soaps, acne preparations with peeling agents, alcohol–{endash}containing preparations, isotretinoin

Lab Tests: Alanine transaminase

Clioquinol

Trade Name(s): Vioform

Chemically Related To: Quinoles

Pregnancy Category: C

Medical Category: Antibacterial (topical), antifungal (topical)

Accepted Indications: Tinea pedis, skin and nail fungal infections, dermal ulcer, tinea capitis

Unaccepted Indications: Diaper rash

Mechanism of Action: Fungistatic, bacteriostatic

Absorption/Distribution: Topical absorption; rapid, 2%–{endash}40%

Research Notes: Broad spectrum; also has minor irritant property

Adult Dosage: Topical b.i.d. or t.i.d.

Elderly Dosage: Same as adult dose

Child Dosage: Same as adult dose

Infant Dosage: Under 2 y: not recommended

Dosage Forms: Cream: 3%; ointment: 3%

By System: Dermal

Precautions: Could stain fabric, skin, nails

Rare Side Effects: Itching, rash, redness

Disease States: Sensitivity to iodine preparations

Other Drugs: Systemic corticosteroids

Lab Tests: Thyroid function, ferric chloride tests for phenylketonuria

Administrative Notes: Incompatible with oxidizing agents

Clioquinol/Hydrocortisone

Trade Name(s): Ala-Quin, Albaform HC, Corque, Iodochlor, Pedi-Cort Vioform HC

Pregnancy Category: C

Medical Category: Topical antifungal, antibacterial

Accepted Indications: Dermatitis, eczema, folliculitis, intertrigo, pruritus, minor bacterial skin infections

Adult Dosage: Topical to the skin t.i.d. or q.i.d.

Child Dosage: Up to 2 y: not recommended; 2 y and over: same as adult dosage

Dosage Forms: Cream 1%/0.5%, 1%/1%, and 3%/1%; lotion 3%/1%; ointment 3%/0.5% and 3%/1%

Clobetasol Propionate

Trade Name(s): Temovate

Chemically Related To: Corticosteroids

Pregnancy Category: C

Medical Category: Topical adrenocorticoid, steroidal anti-inflammatory

Accepted Indications: Skin disorders, alopecia areata, keloids, myxedema, lichen planus, psoriasis, sunburn, sarcoidosis

Unaccepted Indications: Acne, routine gingivitis, rosacea, perioral dermatitis

Mechanism of Action: Forms complexes with cytoplasmic receptors

Absorption/Distribution: Absorbed across the stratum corneum

Metabolism: Skin; if absorbed, hepatic

Elimination: Renal

Research Notes: High-potency adrenocorticoid

Adult Dosage: Apply to skin b.i.d. or t.i.d.

Elderly Dosage: Problems with pre-existing skin atrophy

Child Dosage: Up to 12 y: not recommended

Infant Dosage: Not recommended

Dosage Forms: Cream: 0.05%; ointment: 0.05%; solution: 0.05%

By System: Dermal

Warnings: For external use only; do not use in or around eyes

Precautions: Do not use tight diapers or plastic pants if diaper area is affected

Occasional Side Effects: Contact dermatitis, numbness in fingers, secondary skin infection, skin atrophy, purpura, itching, rash

Rare Side Effects: Acne, Cushing's syndrome, hypopigmentation, loss of hair, secondary glaucoma, hypertension

Antidotal Therapy: No specific antidote; may include dilution with fluids

Disease States: Infection at treatment site, skin atrophy

Lab Tests: Glucose, eosinophil count; hypothalmic-pituitary-adrenal axis function; adrenal function

Clocortolone Pivalate

Trade Name(s): Cloderm

Chemically Related To: Corticosteroids

Pregnancy Category: C

Medical Category: Topical corticosteroid, topical steroidal anti-inflammatory

Accepted Indications: Skin disorders

Unaccepted Indications: Perioral dermatitis, acne

Metabolism: Skin, hepatic

Adult Dosage: Topical to the skin, t.i.d.

Elderly Dosage: Use with caution

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Cream: 0.1%

Occasional Side Effects: Folliculitis, skin atrophy, contact dermatitis, numbness in fingers, purpura

Rare Side Effects: Secondary skin infection, burning or dryness of skin

Antidotal Therapy: May include dilution with fluids

Disease States: Skin atrophy, diabetes, infection at treatment site, glaucoma, tuberculosis

Lab Tests: Glucose, eosinophil count

Clofazimine

Trade Name(s): Lamprene

Pregnancy Category: C

Medical Category: Antibacterial (antimycobacterial)

Accepted Indications: Leprosy (secondary agent), atypical mycobacterial infection

Unaccepted Indications: Other leprosy-associated inflammatory reactions

Mechanism of Action: Bactericidal, inhibits mycobacterial growth, binds to DNA

Half life: 10 d after single dose

PO: 1–{endash}6 h

Metabolism: Hepatic

Elimination: Renal, fecal/biliary, sweat

Research Notes: 3 metabolites identified, with 2 conjugated

Adult Dosage: 50–{endash}100 mg once daily up to 300 mg/d with meals or milk

Elderly Dosage: Same as adult dose

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Capsules: 50 mg and 100 mg

Warnings: May discolor skin and body fluids

Precautions: Avoid sun/sun lamp

Frequent Side Effects: Unusual color of bowel movements and urine, GI upset, rash, itching

Occasional Side Effects: Burning sensation or itching of the eyes, photosensitivity

Rare Side Effects: GI bleeding, hepatitis, jaundice, mental depression

Antidotal Therapy: May include emesis or gastric lavage, supportive treatment

Disease States: Liver and GI problems

Lab Tests: Erythrocyte sedimentation rate; blood glucose; serum potassium, bilirubin, albumin

Administrative Notes: Doses of more than 100 mg must be given with close supervision

Clofibrate

Trade Name(s): Atromid-S

Pregnancy Category: C

Medical Category: Antihyperlipidemic

Accepted Indications: Hyperlipidemia

Unaccepted Indications: Platelet adhesion

Mechanism of Action: Involves inhibition of biosynthesis of cholesterol, decreases LDLs

Half life: 6–{endash}25 h

PO: 3 w with continued use

Metabolism: Hepatic and GI

Elimination: Renal

Research Notes: Long-term use of clofibrate may increase the risk of death from noncardiovascular causes

Adult Dosage: 1.5–{endash}2 g/d in 2–{endash}4 divided doses

Elderly Dosage: Renal function impairment may necessitate change in dosage

Dosage Forms: Capsules: 500 mg

By System: Hepatic

Precautions: If results of hepatic function tests rise significantly, withdraw drug

Frequent Side Effects: Diarrhea, nausea

Occasional Side Effects: Decreased sexual ability, flulike syndrome, headache, stomach pain, gas, stomatitis

Rare Side Effects: Anemia, leukopenia, cardiac arrhythmias, gallstones, renal toxicity

Contraindications: Primary biliary cirrhosis

Overdosage: Chest pain, arrhythmia, shortness of breath, severe stomach pain with nausea and vomiting

Antidotal Therapy: May include supportive measures

Disease States: Cardiovascular disease, gallstones, hepatic and function impairment, hypothyroidism, peptic ulcer

Other Drugs: Rifampin, probenecid, oral contraceptives, oral antidiabetic agents, anticoagulants

Lab Tests: Fibrinogen, amylase, aspartate aminotransferase

Administrative Notes: If response is inadequate after 3 m of treatment, withdraw drug

Clomiphene Citrate

Trade Name(s): Clomid, Milophene, Serophene

Chemically Related To: Estrogen

Pregnancy Category: X

Medical Category: Infertility therapy adjunct; diagnostic ovarian function

Accepted Indications: Infertility

Mechanism of Action: Increases secretion of LH and FSH with ovarian stimulation and LH surge, resulting in development of corpus luteum

Half life: 5–{endash}7 d

PO: Ovulation usually occurs 4–{endash}10 d after last day of treatment

Metabolism: Hepatic

Elimination: Biliary

Research Notes: Asociated with an incidence of multiple pregnancies and possible premature deliveries

Adult Dosage: 25–{endash}50 mg/d up to 250 mg/d to induce ovulation

Dosage Forms: Tablets: 50 mg

By System: Reproductive

Precautions: Caution when driving or doing jobs requiring alertness; possible visual disturbances, dizziness, or lightheadedness

Frequent Side Effects: Ovarian enlargement or cyst formation, uterine fibroid enlargement, premenstrual syndrome, hot flashes

Occasional Side Effects: Persistence of visual images, blurred vision, double vision, photophobia

Rare Side Effects: Breast discomfort, dizziness, headache, mental depression

Contraindications: Hepatic function impairment, mental depression, ovarian cyst, thrombophlebitis

Disease States: Abnormal vaginal bleeding, endometriosis, fibroid tumors of uterus, polycystic ovary syndrome

Lab Tests: Transcortin, sex hormone–{endash}binding globulin

Administrative Notes: Hypoestrogenic patients require pretreatment with estrogen for ovum implant

Clomipramine Hydrochloride

Trade Name(s): Anafranil

Chemically Related To: Imipramine

Pregnancy Category: C

Medical Category: Antidepressant, anti–{endash}obsessive-compulsive, antipanic agent, antineuralgic, anticataplectic, antibulimic

Accepted Indications: Mental depression, obsessive-compulsive disorder, panic disorder, neurogenic pain, vascular headache (prophylaxis), narcolepsy, bulimia

Mechanism of Action: Inhibits reuptake of norepinephrine and/or serotonin

Absorption/Distribution: High protein binding; rapidly absorbed

Half life: 21–{endash}31 h

PO: 6 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Onset of action 2–{endash}3 w

Adult Dosage: 25 mg t.i.d. up to 250 mg/d

Elderly Dosage: 20–{endash}30 mg/d

Child Dosage: Under 10 y: not established; over 10 y: 20–{endash}30 mg/d up to 100 mg

Dosage Forms: Capsules: 25 mg, 50 mg, and 75 mg

By System: CNS, subcortical nuclei

Warnings: May cause drowsiness; avoid alcohol

Precautions: Use sugarless gum or candy for dry mouth; avoid unprotected exposure to sun, sun lamps, and tanning booths

Frequent Side Effects: Dizziness, dry mouth, drowsiness, increased appetite

Occasional Side Effects: Anticholinergic effects, arrhythmia, hypotension, nervousness, parkinsonism

Rare Side Effects: Agranulocytosis, anxiety, tinnitus, testicular swelling, alopecia

Contraindications: Acute recovery period after myocardial infarction

Overdosage: Convulsions, confusion, drowsiness, arrhythmia, fever, hallucinations, vomiting

Antidotal Therapy: May include symptomatic treatment: emesis or gastric lavage; activated charcoal; maintain respiration; lidocaine; digitalize if needed

Disease States: Asthma; blood, convulsive, or bipolar disorders; hyperthyroidism; glaucoma

Other Drugs: Sympathomimetics, MAO inhibitors, estrogens, anticonvulsants, CNS depressants, phenothiazines

Lab Tests: Blood glucose concentrations, metyrapone, EKG changes

Administrative Notes: Strengths of products may not match pediatric and geriatric needs

Clonazepam

Trade Name(s): Klonopin

Chemically Related To: Benzodiazepines

Scheduled Class: IV

Abuse Potential: Mild

Medical Category: Anticonvulsant

Accepted Indications: Epilepsy, absence or myoclonic seizures

Mechanism of Action: Enhances action of GABA

Absorption/Distribution: Well absorbed from GI tract; high protein binding

Half life: 18–{endash}50 h

PO: 1–{endash}2 h

Metabolism: Hepatic

Elimination: Renal, fecal

Research Notes: Drug reaches steady state in 5–{endash}14 d

Adult Dosage: 0.5 mg t.i.d. up to 20 mg/d

Elderly Dosage: Over 70 y: decrease dose

Child Dosage: Under 10 y: 0.01–{endash}0.03 mg/d up to 0.05 mg/kg/d in 2–{endash}3 divided doses

Infant Dosage: There is a possibility of prolonged CNS depression in newborns

Dosage Forms: Tablets: 0.5 mg, 1 mg, and 2 mg

By System: CNS

Warnings: Abrupt withdrawal may cause seizures; tolerance may develop; possibility of prolonged CNS depression in newborns

Precautions: During withdrawal of drug, give another anticonvulsant

Frequent Side Effects: Drowsiness, behavior problems

Occasional Side Effects: GI disturbances, headache, muscle spasm, tachycardia, changes in sexual desire

Rare Side Effects: Seizures, confusion, tingling or burning sensation, hallucinations

Overdosage: CNS depression

Antidotal Therapy: May include supportive measures, including gastric lavage and IV fluids, flumazenil

Disease States: Myasthenia gravis, pulmonary disease, glaucoma

Other Drugs: Alcohol and other CNS depressants

Lab Tests: Metyrapone, sodium iodide I 123 and sodium iodide I 131

Administrative Notes: Maintenance dose based on each individual's response

Clorazepate Dipotassium

Trade Name(s): Gen-XENE, Tranxene-SD, Tranxene T-Tab

Scheduled Class: IV

Abuse Potential: Minor

Pregnancy Category: C

Medical Category: Antianxiety agent, sedative-hypnotic, anticonvulsant

Accepted Indications: Anxiety, alcohol withdrawal, insomnia, convulsions

Mechanism of Action: Depresses limbic and subcortical areas of brain, suppresses speed of seizure activity

Absorption/Distribution: High protein binding; rapidly absorbed

Half life: 30–{endash}100 h

PO: 0.5–{endash}2 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Steady-state plasma concentration in 5 d–{endash}2 w

Adult Dosage: Antianxiety agent: 7.5–{endash}15 mg b.i.d. to q.i.d.; alcohol withdrawal: 30 mg initially, followed by 15 mg b.i.d. to q.i.d. the first day, 15 mg 3–{endash}6 times/d on second day, 7.5–{endash}15 mg t.i.d. the third day, 7.5 mg b.i.d. to q.i.d. the fourth day, thereafter 3.75 mg b.i.d. to q.i.d.; anticonvulsant: initially up to 7.5 mg t.i.d., the dosage increased by no more than 7.5 mg/w, not to exceed 90 mg/d

Elderly Dosage: Antianxiety agent: 3.75–{endash}15 mg/d, dosage increased as needed

Child Dosage: Anticonvulsant: up to 9y: safety and efficacy not established; 9–{endash}12 y: up to 7.5 mg b.i.d. dosage increased up to 60 mg/d; 12 y and over: same as adult dosage

Dosage Forms: Capsules: 3.75 mg, 7.5 mg, and 15 mg; tablets: 3.75 mg, 7.5 mg, 11.25 mg, 15mg, and 22.5 mg

By System: CNS, subcortical nuclei

Warnings: May cause drowsiness; avoid alcohol

Occasional Side Effects: Stomach cramps, confusion, increased sweating, nausea and vomiting, trembling, palpitations, drowsiness

Rare Side Effects: Convulsions, delirium, hallucinations

Overdosage: Confusion, decreased reflexes, bradycardia, severe weakness, shortness of breath

Antidotal Therapy: May include emesis or gastric lavage; activated charcoal; monitor respiration and blood pressure; IV fluids and vasopressors, flumazenil

Disease States: Glaucoma, shock, convulsions, liver or kidney failure, psychosis, sleep apnea, myasthenia gravis

Other Drugs: CNS depressants, tricyclic antidepressants, erythromycin, estrogen–{endash}containing contraceptives, zidovudine, levodopa, scopolamine

Lab Tests: Metyrapone, sodium iodide I 123 and sodium iodide I 131

Clotrimazole

Trade Name(s): Lotrimin, Mycelex

Chemically Related To: Ketoconazole

Pregnancy Category: B

Medical Category: Antifungal

Accepted Indications: Candidiasis, tinea corporis, tinea cruris, tinea pedis, tinea versicolor

Unaccepted Indications: Vulvovaginitis caused by bacterial pathogens

Mechanism of Action: Inhibits biosynthesis of ergosterol, damaging the fungal cell wall membrane and altering its permeability.

Absorption/Distribution: Oral: poor, even when swallowed; topical: dermal penetration; minimal systemic absorption

Metabolism: Hepatic

Elimination: Fecal

Research Notes: May affect the performance of some contraceptive devices

Adult Dosage: Topically b.i.d.

Elderly Dosage: Same as adult dose

Child Dosage: Same as adult dose

Infant Dosage: Same as adult dose

Dosage Forms: Cream, lotion, solution

By System: Immunologic

Warnings: Continue medicine for full course of treatment

Precautions: GI problems; may lead to skin sensitization

Occasional Side Effects: Vaginal burning, itching, discharge, abdominal or stomach cramps, headache

Disease States: Bacterial infections

Administrative Notes: Continue for full time of treatment

Cloxacillin Sodium

Trade Name(s): Cloxapen, Tegopen

Chemically Related To: Penicillin

Pregnancy Category: B

Medical Category: Antibacterial

Accepted Indications: Pneumonia (staphylococcal), sinusitis, skin and soft tissue infection, biliary tract infection, bacterial endocarditis

Unaccepted Indications: Meningitis

Mechanism of Action: Inhibits cell wall synthesis

Absorption/Distribution: 50% absorbed; high protein binding

Half life: 0.5–{endash}1.1 h

PO: 1–{endash}2 h

Metabolism: Hepatic

Elimination: Renal

Research Notes: Penicillinase-resistant

Adult Dosage: 250–{endash}500 mg q.i.d. up to 6 g/d

Elderly Dosage: May require a lower dosage

Child Dosage: Up to 20 kg: 6.25–{endash}12.5 mg/kg q.i.d.; over 20 kg: same as adult dose

Infant Dosage: Same as child dose

Dosage Forms: Capsules: 250 mg and 500 mg; oral solution: 125 mg/5mL

By System: Systemic

Warnings: Take for full time of treatment

Precautions: Possible need for alternative contraceptives

Frequent Side Effects: GI upset, candidiasis

Rare Side Effects: Allergic or serum sickness reaction, convulsions, pseudomembranous colitis

Contraindications: Allergy to penicillins, penicillamine

Overdosage: Severe diarrhea, nausea and vomiting

Antidotal Therapy: No specific antidote; may include supportive treatment, possible hemodialysis

Disease States: History of bleeding disorders, GI problems, infectious mononucleosis, and liver problems

Other Drugs: NSAIDs, thrombolytic agents, estrogen contraceptives, probenecid, hepatotoxic medications

Lab Tests: Bleeding time, urine glucose and protein, Coombs' test, hyperkalemia, serum uric acid and bilirubin

Administrative Notes: Take on an empty stomach

Clozapine

Trade Name(s): Clozaril, Leponex

Chemically Related To: Tricyclic antidepressants

Pregnancy Category: B

Medical Category: Antipsychotic

Accepted Indications: Schizophrenia

Mechanism of Action: Interferes with binding of dopamine

Absorption/Distribution: Rapid and nearly complete absorption; rapid distribution

Half life: 8 h

PO: 2.5 h

Metabolism: Hepatic

Elimination: Renal/fecal

Research Notes: Duration of action 4-12 h

Adult Dosage: Initially, 25 mg once daily or b.i.d., working up to 300–{endash}450 mg/d; maximum of 900 mg/d

Elderly Dosage: Confusion and excitement may occur more often

Child Dosage: Safety not established

Dosage Forms: Tablets: 25 mg and 100 mg

By System: CNS, subcortical nuclei

Warnings: May cause drowsiness; avoid alcohol

Precautions: Caution when getting up

Frequent Side Effects: Tachycardia, fever, orthostatic hypotension

Occasional Side Effects: Agitation, akathisia, confusion, blurred vision, hypertension, fainting

Rare Side Effects: Blood dyscrasias, eosinophilia, insomnia, depression, convulsions, neuroleptic malignant syndrome

Contraindications: Severe CNS depression, blood dyscrasias, bone marrow depression

Antidotal Therapy: No specific antidote; may include emesis, gastric lavage, or activated charcoal; maintain airway

Disease States: Heart problems, GI disorders, glaucoma, liver or kidney problems, prostatic hypertrophy

Other Drugs: CNS depressants, bone marrow depressants, lithium, digoxin, anticholinergics

Lab Tests: Negative blood test result for agranulocytosis before refills authorized

Administrative Notes: Dosage individualized by titration, requires close monitoring

Coal Tar

Trade Name(s): Aquatar, Denorex Extra Strength Medicated Shampoo, Estar, Zetar Emulsion

Chemically Related To: Unique compound

Pregnancy Category: C

Medical Category: Keratolytic, antipsoriatic, antiseborrheic

Accepted Indications: Dandruff, seborrheic or atopic dermatitis, eczema, psoriasis

Mechanism of Action: Suppresses hyperplastic skin in proliferative disorders; vasoconstrictor activity

Absorption/Distribution: Dermal

Research Notes: Induces photosensitivity

Adult Dosage: Topical to the skin or scalp

Dosage Forms: Cleansing bar, cream, gel, lotion, ointment, shampoo, solution, suspension

By System: Dermal

Warnings: Temporarily discolors blond, bleached, or tinted hair; stains skin and clothing

Precautions: Protect treated area from direct sunlight for 72 h after application of medication; do not apply to infected or oozing areas of skin

Frequent Side Effects: Stinging at application site

Rare Side Effects: Irritant contact dermatitis

Disease States: Acute inflammation, open wounds, skin infection

Other Drugs: Photosensitizing medications, such as diuretics

Administrative Notes: When used in conjunction with UV light or sunlight, exposure to light may be undertaken 2–{endash}72 h after coal tar is applied

Cocaine Hydrochloride

Trade Name(s): Generic only

Chemically Related To: Atropine

Scheduled Class: II

Abuse Potential: High

Pregnancy Category: C

Medical Category: Anesthetic, vasoconstrictor (mucosal, local)

Accepted Indications: Local pain

Unaccepted Indications: CNS stimulation

Mechanism of Action: Decreases the neuronal membrane's permeability to sodium ions; indirect acting sympathomimetic

Absorption/Distribution: Readily absorbed from all mucous membranes

Half life: 1–{endash}1.5 h

Peak activity: Mucosal 5 m

Metabolism: Hydrolyzed by plasma and hepatic cholinesterases

Elimination: Renal

Research Notes: Onset of action 1 min; duration of action 30 min–{endash}1 h, depending on concentration

Adult Dosage: 400 mg prescribing limit; lowest effctive dosage recommended

Elderly Dosage: Reduction in dosage recommended; more likely to have cerebrovascular disease

Child Dosage: Under 6 y: not recommended; 6 y and older: individualized

Dosage Forms: Crystals/flakes; tablets for topical solution: 135 mg; topical solution: 4% and 10 %; viscous topical solution: 4% and 10%

By System: Mucous membranes

Warnings: Tolerance to the anesthetic effects with repeated application

Frequent Side Effects: Loss of smell and/or taste, rebound nasal congestion, chronic rhinitis

Rare Side Effects: Cardiovascular collapse

Overdosage: Cardiac/cardiovascular effects, chills and fever, excitement and rapid breathing, unusually large pupils

Antidotal Therapy: May include use of supportive measures

Disease States: Cardiovascular disease, convulsions, hypertension, thyrotoxicosis, local infection, Tourette's syndrome, severe traumatized mucosa

Other Drugs: Amphetamines, appetite suppressants, beta-blockers, MAO inhibitors, sympathomimetics, thyroid hormones, nitrates, methyldopa, levodopa, antihypertensives, inhalational anesthetics

Lab Tests: Blood pressure, body temperature, heart rate, blood glucose concentration

Codeine Phosphate

Trade Name(s): Generic only

Chemically Related To: Morphine

Scheduled Class: II

Abuse Potential: Moderate

Pregnancy Category: C

Medical Category: Analgesic, antitussive, antidiarrheal

Accepted Indications: Mild to moderate pain, cough, diarrhea

Mechanism of Action: Exerts agonist activity at mu receptor in CNS to control pain

Absorption/Distribution: All body tissues

Half life: 2.5–{endash}4 h

PO: 1–{endash}2 h

IM: 30–{endash}60 min

Metabolism: Hepatic

Elimination: Renal

Research Notes: 120 mg IM or 200 mg PO therapeutically equivalent to 10 mg of IM morphine

Adult Dosage: Analgesic: oral and injection 15–{endash}60 mg q3h–{endash}q.i.d; Antidiarrheal: oral 30 mg up to q.i.d; Antitussive: oral 10–{endash}20 mg q4h–{endash}q.i.d

Child Dosage: Analgesic: oral and injection 500 m{mu}g/kg q4h–{endash}q.i.d.; Anitdiarrheal: 500 m{mu}g/kg up to q.i.d.; Anititussive: up to 2 y not recommended, 2–{endash}5 y 1mg/kg/d q.i.d.

Infant Dosage: Newborn, not established

Dosage Forms: Oral solution 15 mg/5 mL, tablets 30 and 60 mg, injection 30 and 60 mg/mL

By System: CNS subcortical nuclei at mu receptor

Warnings: Avoid alcoholic beverages and other CNS depressants

Precautions: Do not drive or operate machinery

Frequent Side Effects: Constipation, drowsiness

Occasional Side Effects: CNS stimulation, confusion, arrhythmia, decreased urination, blurred vision, dry mouth, headache

Rare Side Effects: Convulsions, hallucinations, mental depression, muscle rigidity, trembling, biliary spasm, GI irritation, nervousness, nightmares

Contraindications: Acute respiratory depression, diarrhea associated with colitis

Overdosage: Severe drowsiness, hypotension, nervousness, bradycardia, slow or troubled breathing

Antidotal Therapy: May include naloxone 400 m{mu}g–{endash}2 mg

Disease States: Acute asthma, cardiac arrhythmias, convulsions, gallstones, head injury

Other Drugs: CNS depressants, anticholinergics, antihypertensives, antiperistaltics, antidiarrheals, MAO inhibitors, naloxone, naltrexone, neuromuscular blocking agents, zidovudine, rifampin

Lab Tests: Serum alkaline phosphatase, bilirubin, plasma lipase activity

Administrative Notes: Codeine more likely than most other opioids to cause constipation but has a lower dependence liability

Codeine Phosphate/Ephedrine Hydrochloride/Guaifenesin

Trade Name(s): Broncholate CS Syrup

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Bronchodilator, expectorant

Accepted Indications: Cough

Dosage Forms: Syrup: 10 mg/6.25 mg/100 mg/5 mL

Codeine Phosphate/Guaifenesin

Trade Name(s): Baytussin A.C., Glydeine, Guaituss AC, Halotussin-DAC, Medi-Tuss with Codeine, Mytussin AC, Nortussin w/Codeine, Robitussin AC, Tolu-Sed

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive, mucolytic

Accepted Indications: Coughs and colds

Adult Dosage: Syrup: 5–{endash}10 mL q4h; tablets: 1q4h

Child Dosage: 2–{endash}6 y: syrup, 2.5 mL; 6–{endash}12 y: syrup, 5 mL q4–{endash}6h

Dosage Forms: Syrup: 10 mg/100 mg/5 mL; tablets 10 mg/300 mg; oral solution: 10 mg/100 mg

Codeine Phosphate/Guaifenesin/Phenylpropanolamine

Trade Name(s): Chemdal, Codegest, Endal, Naldecon-CX, Novagest, Triaminic Expectorant with Codeine

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive, decongestant, mucolytic

Accepted Indications: Coughs and colds

Adult Dosage: 5–{endash}10 mL t.i.d. or q.i.d.

Child Dosage: 2–{endash}6 y: 1.25–{endash}2.5 mL; 6–{endash}12 y: 2.5–{endash}5 mL every 4–{endash}6 h

Dosage Forms: Oral solution: 10 mg/100 mg/12.5 mg

Codeine Phosphate/Guaifenesin/Pseudoephedrine Hydrochloride

Trade Name(s): Alamine, Benylin with Codeine, Deconsal Pediatric Syrup, Deproist with Codeine, Dihistine, Guiatuss DAC, Guiatussin DAC, Mytussin DAC, Novagest with Codeine, Novahistine, Nucochem, Nucochem Pediatric, Nucofed, Nucofed Pediatric, Nucotuss, Nucotuss Pediatric, Phenhist, Robafen DAC, Robitussin-DAC, Ryna-CX, Tussar SF, Tussar-2

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive, mucolytic, decongestant

Accepted Indications: Cough and cold

Adult Dosage: 10 mL q4h

Child Dosage: 2–{endash}6 y: 1.25–{endash}2.5 mL; 6–{endash}12 y: 2.5–{endash}5 mL q4–{endash}6h

Dosage Forms: Syrup 10 mg/100 mg/30 mg

Codeine Phosphate/Iodinated Glycerol

Trade Name(s): Io Tuss, Iophen-C, Tussi-Organidin

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive

Accepted Indications: Cough

Adult Dosage: 5–{endash}10 mL every 4 h

Child Dosage: 2–{endash}6 y: 1.25–{endash}2.5 mL; 6–{endash}12 y: 2.5–{endash}5 mL t.i.d. or q.i.d.

Dosage Forms: Oral solution: 10 mg/30 mg

Codeine Phosphate/Phenylephrine Hydrochloride/Promethazine Hydrochloride

Trade Name(s): M-Phen, Para-Hist, Phenergan VC with Codeine, Pherazine VC with Codeine

Pregnancy Category: C

Medical Category: Antihistamine, antitussive, decongestant

Accepted Indications: Allergies, coughs, and colds

Adult Dosage: 5 mL every 4–{endash}6 h

Child Dosage: Under 6 y: 1.25–{endash}2.5 mL every 4–{endash}6 h; 6–{endash}12 y: 2.5–{endash}5 mL every 4–{endash}6 h

Dosage Forms: Syrup: 10 mg/5 mg/6.25 mg/5 mL

Codeine Phosphate/Phenylephrine Hydrochloride/Pyrilamine Maleate

Trade Name(s): Codimal PH

Scheduled Class: V

Abuse Potential: Moderate

Pregnancy Category: C

Medical Category: Antitussive, decongestant, antihistamine

Accepted Indications: Coughs and colds

Adult Dosage: 5–{endash}10 mL every 4–{endash}6 h

Dosage Forms: Syrup: 10 mg/5 mg/8.33 mg/5 mL

Codeine Phosphate/Promethazine Hydrochloride

Trade Name(s): Dectuss, Phenergan with Codeine, Pherazine with Codeine, Prothazine

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antihistamine, antitussive

Accepted Indications: Coughs and colds

Adult Dosage: 5 mL every 4–{endash}6 h

Child Dosage: Under 6 y: 1.25–{endash}2.5 mL every 4–{endash}6 h; 6–{endash}12 y: 2.5–{endash}5 mL every 4–{endash}6 h

Dosage Forms: Syrup: 10 mg/6.25 mg/5 mL

Codeine Phosphate/Terpin Hydrate

Trade Name(s): Prunicodeine

Scheduled Class: V

Abuse Potential: Low

Pregnancy Category: C

Medical Category: Antitussive

Accepted Indications: Cough

Dosage Forms: Elixir: 10 mg/85 mg

Colchicine

Trade Name(s): Generic only

Chemically Related To: Quinidine

Pregnancy Category: D

Medical Category: Antigout agent

Accepted Indications: Acute and chronic gouty arthritis

Mechanism of Action: Decreases leukocyte motility, phagocytosis, and lactic acid production, which decreases urate crystals and inflammation

Half life: Biphasic: 3–{endash}5 min distribution, 1 h elimination

PO: 24–{endash}48 h after first PO dose for acute pain relief

Metabolism: Hepatic

Elimination: Biliary

Research Notes: Decreases body temperature, depresses the respiratory center, and constricts blood vessels

Adult Dosage: Tablets: prophylactic 500–{endash}600 m{mu}g 1–{endash}3 times/d; for relief of acute attack, 500 m{mu}g–{endash}1.2 mg initially and then 500–{endash}600 m{mu}g every 1–{endash}2 h or 1–{endash}1.2 mg every 2 h to a maximum of 6 mg. IV: as prophylactic, 500 m{mu}g–{endash}1 mg once daily or b.i.d.; for relief of acute attack, 2 mg initially and then 500 m{mu}g q.i.d. or 1 mg b.i.d.–{endash}q.i.d. to a maximum of 4 mg.

Elderly Dosage: Elderly patients more susceptible to cumulative toxicity

Child Dosage: Safety and efficacy not established

Infant Dosage: Safety and efficacy not established

Dosage Forms: Tablets: 500 m{mu}g and 600 m{mu}g; IV 1 mg/2 mL

By System: Immune tissues

Warnings: Large amounts of alcohol may increase the risk of GI toxicity, also may increase uric acid concentrations

Precautions: If diarrhea, nausea, vomiting, or stomach pain continues for more than 3 h after medication is discontinued, call physician

Frequent Side Effects: Diarrhea, nausea or vomiting, stomach pain

Occasional Side Effects: Loss of appetite, hair loss

Rare Side Effects: Thrombophlebitis at injection site, agranulocytosis, aplastic anemia, peripheral neuritis, rash, thrombocytopenia

Overdosage: Burning sensation in stomach, throat, or skin; convulsions; diarrhea; fever; mood or mental change; muscle weakness; pulmonary edema; respiratory depression; renal failure

Antidotal Therapy: May include administration of antidiarrheal or atropine; gastric lavage; correction of electrolyte imbalance and metabolic acidosis

Disease States: Alcoholism, blood dyscrasias, severe cardiac disorder or GI disorders, renal function impairment

Other Drugs: Alcohol, NSAIDs, antineoplastic agents, diuretics, bone marrow depressants, vitamin B12, radiation therapy

Lab Tests: Urine tests for red blood cells, platelet count

Administrative Notes: When used intermittently to relieve acute attacks, an interval of 3 d between courses of therapy is recommended to reduce the risk of cumulative toxicity

Colchicine/Probenecid

Trade Name(s): Colbenemid, Col-Probenecid, Proben-C

Pregnancy Category: C

Medical Category: Antigout

Accepted Indications: Gouty arthritis

Adult Dosage: 1 tablet once daily for 1 w, followed by 1 tablet b.i.d. thereafter

Elderly Dosage: Lower dose may be required

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Tablets: 0.5 mg/500 mg

Colestipol Hydrochloride

Trade Name(s): Colestid

Chemically Related To: Anion-exchange resin

Pregnancy Category: C

Medical Category: Antihyperlipidemic, antipruritic (cholestasis), antidiarrheal (bile acid)

Accepted Indications: Hyperlipidemia, pruritus due to biliary obstruction

Mechanism of Action: Binds with bile acids in the intestine, preventing reabsorption and producing a complex that is excreted in the feces

Absorption/Distribution: Not absorbed from GI tract

PO: 1 h

Elimination: Fecal

Research Notes: After withdrawal, cholesterol concentrations return to baseline in about 1 m

Adult Dosage: 15–{endash}30 g daily in 2–{endash}4 divided doses

Elderly Dosage: Patients over 60 y more likely to experience GI side effects and adverse nutritional effects

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: For oral suspension: 5 g/packet or level scoop

By System: GI tract

Warnings: Not recommended in children under 2 y because cholesterol is required for normal development

Frequent Side Effects: Constipation

Occasional Side Effects: Belching, bloating, diarrhea, dizziness, headache, nausea and vomiting, stomach pain

Rare Side Effects: Gallstones, GI bleeding, peptic ulcer

Contraindications: Primary biliary cirrhosis

Disease States: Bleeding disorders, gallstones, GI dysfunction, peptic ulcer, constipation, hemorrhoids, renal function impairment

Other Drugs: Anticoagulants, digitalis glycosides, thiazide diuretics, penicillin G, tetracyclines, fat-soluble vitamins

Lab Tests: Serum chloride, phosphorus, potassium and sodium levels; prothrombin time, alkaline phosphatase

Administrative Notes: Diet is preferred therapy; compliance with prescribed diet needed. If constipation occurs or worsens, reduce dose to prevent impaction.

Colistimethate Sodium

Trade Name(s): Coly-Mycin M

Chemically Related To: Polymyxins

Pregnancy Category: Safety not established

Medical Category: Polymyxin antibiotic

Accepted Indications: Acute or chronic infections caused by strains of gram-negative bacteria, urinary tract infections caused by Pseudomonas aeruginosa.

Unaccepted Indications: Infections caused by Proteus or Neisseria

Mechanism of Action: Bactericidal

Absorption/Distribution: Not absorbed from GI tract

Half life: 2–{endash}3 h

IM: 2–{endash}3 h

IV: 10 min

Elimination: Renal

Research Notes: Transferred across placental barrier

Adult Dosage: 2.5–{endash}5 mg/kg/d in 2–{endash}4 doses IM or IV

Elderly Dosage: Renal problems could require caution

Child Dosage: Same as adult dose

Infant Dosage: Pay close attention to renal function

Dosage Forms: Parenteral: 150 mg/vial

Precautions: Use caution in women of childbearing potential

Occasional Side Effects: Numbness, dizziness, blurred vision, slurred speech, pruritus, rash, tingling sensation in the extremities

Overdosage: Kidney problems, muscle weakness, apnea

Antidotal Therapy: May include assisted respiration, oxygen, calcium chloride injection

Disease States: Kidney problems

Other Drugs: Kanamycin, streptomycin, dihydrostreptomycin, polymyxin B sulfate, neomycin, curariform muscle relaxants, aminoglycosides, amphotericin B, capreomycin, methoxyflurane, vancomycin, cephalothin

Lab Tests: BUN, serum creatinine

Collagenase

Trade Name(s): Santyl

Chemically Related To: Enzymes

Medical Category: Skin and mucous membrane agent

Accepted Indications: Debridement of necrotic tissue in severe burns and dermal ulcers

Mechanism of Action: Hydrolyzes peptide bonds of collagen

Research Notes: Does not degrade fat, keratin, fibrin or hemoglobin; optimal activity pH 7-8

Adult Dosage: Apply topically as an ointment once daily for hospitalized patients and every other day for outpatients

Dosage Forms: Ointment: 250 units/g

By System: Dermal

Warnings: Apply with caution near the eyes

Precautions: Observe for signs of systemic bacterial infection

Side/Adverse Effects: Pain and burning at site of application or slight erythema in surrounding tissue

Antidotal Therapy: May include application of Burow's solution USP (pH 3.6–{endash}4.4)

Other Drugs: Detergents, hexachlorophene, mercury and silver antiseptics, benzalkonium chloride, nitrofurazone, tincture of iodine

Administrative Notes: Apply aluminum acetate solution to surrounding skin to terminate drug's activity

Cortisone Acetate

Trade Name(s): Cortone, Cortone Acetate

Pregnancy Category: Adequate studies have not been done

Medical Category: Corticosteroid, anti-inflammatory, immunosuppressant

Accepted Indications: Adrenocortical insufficiency, allergic disorders, dermatologic disorders, hematologic disorders, inflammation, ophthalmic disorders, respiratory disorders, rheumatic disorders

Absorption/Distribution: Rapidly absorbed

PO: 2 h

IM: 20–{endash}48 h

Metabolism: Hepatic, renal, tissue

Elimination: Renal

Research Notes: Duration of action 1.25–{endash}1.5 d

Adult Dosage: 25–{endash}300 mg/d

Elderly Dosage: Use with caution

Child Dosage: 700 m{mu}g–{endash}10 mg/kg/d in divided doses

Dosage Forms: Tablets: 5 mg, 10 mg and 25 mg. Suspension: 25 mg/mL and 50 mg/mL.

Frequent Side Effects: Nervousness, acne, increased appetite, indigestion, trouble sleeping

Occasional Side Effects: Change in skin color, allergic reaction, cataracts, diabetes mellitus, dizziness, increased sweating, osteoporosis

Rare Side Effects: Avascular necrosis of bone, Cushing's syndrome, sudden blindness, psychic disturbances, disorientation, euphoria, hallucinations, manic-depressive episodes, mental depression, anaphylaxis, flushing, pounding heartbeat, seizures, generalized allergic reaction, reaction at injection site

Contraindications: Blood clotting syndromes, infections, osteoporosis, intestinal obstruction

Disease States: Herpes simplex, systemic lupus erythematosus, tuberculosis, fungal infections, diabetes, joint arthroplasty, intra-articular fracture, periarticular infection, unstable joint, chicken pox, measles, myasthenia gravis, cardiac disease, CHF, renal function impairment, peptic ulcer, AIDS, HIV, diabetes mellitus

Other Drugs: Amphotericin B, antidiabetic agents, insulin, digitalis glycosides, diuretics, hepatic enzyme–{endash}inducing agents, potassium supplements, ritodrine, sodium–{endash}containing medications, somatrem, somatropin, live virus vaccines

Lab Tests: Glucose, cholesterol, potassium

Cromolyn Sodium

Trade Name(s): Gastrocrom, Intal, Nasalcrom

Chemically Related To: Unique compound

Pregnancy Category: B

Medical Category: Mast cell stabilizer, antiallergic

Accepted Indications: Allergy, bronchial asthma, mastocytosis

Mechanism of Action: Inhibits mast cell release of histamine and other substances that cause hypersensitivity reactions or histamine release

Absorption/Distribution: Poorly absorbed from GI tract; usually administered topically to site of action

Half life: 80 min

Elimination: Renal/biliary

Adult Dosage: Inhalation aerosol: 1.6 mg q.i.d.; capsules for inhalation: 20 mg q.i.d.; nasal solution: 5.2 mg t.i.d. or q.i.d.; systemic/oral capsules 800 mg/d 30 min before meals and at bedtime

Elderly Dosage: Hepatic and renal impairment could necessitate a decreased dose

Child Dosage: Up to 5 y, inhalation aerosol: safety and efficacy not established; 5 y and over: same as adult dose. Capsules for inhalation, up to 2 y: safety and efficacy not established; 2 y and over: same as adult dose. Nasal solution, up to 6 y: safety and efficacy not established; 6 y and over: same as adult dose. Capsules, up to 2 y: 20 mg/kg/d in 4 divided doses; 2–{endash}12 y: 400 mg/d; 30 min before meals and at bedtime

Dosage Forms: Inhalation aerosol: 0.8 mg/metered spray; capsules for inhalation: 20 mg; nasal solution: 40 mg/mL (5.2 mg/metered spray); oral capsules: 100 mg (mastocytosis only, not for inhalation)

Precautions: Check with physician if symptoms do not improve or condition worsens

Frequent Side Effects: Diarrhea, headache, increased bronchospasm, burning sensation or stinging inside of nose

Occasional Side Effects: Rash, abdominal pain, irritability, joint pain, nausea, trouble sleeping, cough, postnasal drip

Rare Side Effects: Anaphylactic reaction, angioedema, dizziness, painful urination, eosinophilic pneumonia, muscle pain or weakness, rash, hives, itching, epistaxis

Contraindications: Severe hepatic or renal function impairment

Disease States: Hepatic and renal impairment

Nutrition: Do not mix oral capsule medication with food, milk, or fruit juices

Other Drugs: Methacholine

Administrative Notes: For optimal results for mastocytosis, dissolve contents of the capsules for inhalation in warm water and take as a solution. For optimal results with inhalation capsules, must be used as instructed with special inhaler

Crotamiton

Trade Name(s): Eurax

Chemically Related To: Unique compound

Pregnancy Category: C

Medical Category: Scabicide

Accepted Indications: Scabies

Unaccepted Indications: Pruritus associated with dermatoses

Research Notes: Skin should be well dried before medication is applied

Adult Dosage: Topical to the skin

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Cream: 10%; lotion: 10%

By System: Dermal

Warnings: Hygienic measures needed to control reinfestation

Rare Side Effects: Allergic skin reaction

Antidotal Therapy: No specific antidote; if ingested, gastric lavage should be performed

Disease States: Acutely inflamed skin or raw oozing skin surface

Administrative Notes: Necessary for all household members to receive treatment if medication is being used for scabies

Cyanocobalamin

Trade Name(s): Crystamine, Crysti-12, Cyanoject, Cyomin, Rubesol-1000, Rubramin PC

Chemically Related To: Vitamin B12

Pregnancy Category: C

Medical Category: Nutritional supplement, antianemic, diagnostic aid

Accepted Indications: Pernicious anemia, vitamin deficiency

Unaccepted Indications: Viral hepatitis, angina, delayed growth, sterility, allergies, amblyopia, poor appetite, malnutrition, dermatologic disorders, fatigue, mental disorders, multiple sclerosis, thyrotoxicosis, trigeminal neuralgia

Mechanism of Action: Acts as coenzyme for metabolic functions

Half life: 6 d (plasma), 400 days (liver)

PO: 8–{endash}12 h

IM: 60 min

IV: 1 h

Metabolism: Hepatic storage

Elimination: Biliary

Adult Dosage: Tablets: 0.001 mg–{endash}0.025 mg/d; injection, initial, IM or SQ: 0.1 mg/d for 6–{endash}7 d, followed by 0.1 mg every other day for 7 doses, then 0.1 mg every 3–{endash}4 d for another 2–{endash}3 w; maintenance, IM: 0.1–{endash}0.2 mg once/m

Elderly Dosage: Same as adult dose

Child Dosage: Tablets: 1 y and over: 0.001 mg/d; injection, initial, IM or SQ: 0.03–{endash}0.05 mg/d for 2 or more w; maintenance, IM or SQ: 0.1 mg once/m

Infant Dosage: Tablets: up to 1 y: 0.0003 mg/d

Dosage Forms: Tablets: 0.025 mg, 0.05 mg, 0.1 mg, 0.25 mg, 0.5 mg, and 1 mg; injection: 0.03 mg/mL, 0.1 mg/mL, and 1 mg/mL

Warnings: Megadoses not recommended

Occasional Side Effects: Diarrhea, itching of skin

Rare Side Effects: Anaphylaxis

Contraindications: Leber's disease

Other Drugs: Excessive alcohol, antibiotics, ascorbic acid, folic acid, aminosalicylates, colchicine

Lab Tests: Folic acid concentrations, hematocrit, potassium concentrations

Administrative Notes: Need for lifelong therapy for pernicious anemia

Cyclizine Lactate

Trade Name(s): Marezine

Pregnancy Category: Problems in humans not documented

Medical Category: Antiemetic, antihistamine

Accepted Indications: Motion sickness, vomiting

Mechanism of Action: Diminishes vestibular stimulation

Adult Dosage: Tablets: 50 mg,30 min before travel, repeated q4–{endash}6h, up to 200 mg/d. Injection: IM, 50 mg q4–{endash}6h.

Elderly Dosage: Same as adult dose

Child Dosage: Tablets: 6–{endash}12 y: 25 mg, 30 min before travel; repeated t.i.d. or q.i.d. Injection: IM, 1 mg/kg t.i.d.

Infant Dosage: Tablets: 1 mg/kg t.i.d.

Dosage Forms: Tablets: 50 mg. Injection: 50 mg/mL.

Frequent Side Effects: Drowsiness

Occasional Side Effects: Constipation, blurred vision, difficult urination, dizziness, dry mouth, tachycardia, appetite loss, restlessness, nervousness, rash, trouble sleeping, GI upset

Disease States: Severe cardiac failure, glaucoma, bladder neck obstruction, prostatic hypertrophy, pyloroduodenal obstruction

Other Drugs: CNS depressants, anticholinergics, apomorphine

Administrative Notes: Avoid alcohol

Cyclobenzaprine Hydrochloride

Trade Name(s): Cycoflex, Flexeril

Chemically Related To: Tricyclic antidepressants

Pregnancy Category: B

Medical Category: Skeletal muscle relaxant

Accepted Indications: Skeletal muscle pain, sedative

Mechanism of Action: Acts at brainstem to reduce tonic somatic motor activity

Absorption/Distribution: Slowly absorbed; distributed in all body tissues

Half life: 1–{endash}3 d

PO: 1–{endash}2 w

Metabolism: GI and hepatic

Elimination: Renal

Research Notes: Duration of action of a single dose, 12–{endash}24 h

Adult Dosage: 5–{endash}60 mg/d

Elderly Dosage: Not listed

Child Dosage: Not established

Infant Dosage: Not established

Dosage Forms: Tablets: 10 mg

By System: Parasympathetic; CNS

Warnings: May cause drowsiness; avoid alcoholic beverages

Precautions: Caution if blurred vision, drowsiness, or dizziness occurs; possible dry mouth

Frequent Side Effects: Dry mouth, dizziness, drowsiness

Occasional Side Effects: Headache, confusion, constipation, GI irritation, tachycardia, unpleasant taste, allergy

Rare Side Effects: Problems in urination, dreaming, clumsiness, mental depression

Contraindications: Acute recovery phase of myocardial infarction, cardiac arrhythmias, CHF, heart block, hyperthyroidism

Overdosage: Cardiotoxicity; severe confusion; convulsions; hallucinations; dry, hot, flushed skin; increased or decreased body temperature; unexplained muscle stiffness; vomiting

Antidotal Therapy: May include supportive and maintenance therapy

Disease States: Glaucoma, urinary retention

Other Drugs: Antidepressants, CNS depressants, antidyskinetics, anticholinergics, guanethidine, MAO inhibitors

Administrative Notes: Recommended that therapy for acute, painful musculoskeletal conditions be discontinued after 2–{endash}3 w

Cyclopentolate Hydrochloride

Trade Name(s): Ak-Pentolate, Cyclogyl, Pentolair

Chemically Related To: Anticholinergics

Pregnancy Category: C

Medical Category: Cycloplegic, mydriatic

Accepted Indications: Cycloplegic refraction, mydriasis, posterior synechia prophylaxis, uveitis

Mechanism of Action: Anticholinergic

Peak activity: Cycloplegia, 25–{endash}75 min; mydriasis, within 1 h

Research Notes: Onset of action rapid, with a shorter duration of action than atropine

Adult Dosage: Topical to the conjunctiva, 1 drop of 0.5%–{endash}2% solution

Elderly Dosage: Increased potential for systemic side effects

Child Dosage: Same as adult dose

Infant Dosage: Topical, to the conjunctiva, 1 drop of 0.5% solution

Dosage Forms: Solution .5%, 1%, and 2%

By System: Ophthalmic

Warnings: For the eye; keep container tightly closed

Precautions: Wash hands immediately after application

Overdosage: With systemic absorption, ataxia, confusion, fever, hallucinations, thirst, weakness, flushing

Antidotal Therapy: May include physostigmine

Disease States: Brain damage in children, Down syndrome, spastic paralysis in children, glaucoma

Other Drugs: Antiglaucoma agents, carbachol, pilocarpine

Administrative Notes: Monitor infants for 30 min after administration

Cyclophosphamide

Trade Name(s): Cytoxan, Neosar

Chemically Related To: Nitrogen mustard

Pregnancy Category: D

Medical Category: Antineoplastic, immunosuppressant

Accepted Indications: Leukemias, lymphomas, ovarian and breast carcinoma, nephrotic syndrome, vasculitis, systemic lupus erythematosus

Mechanism of Action: Cross-links strands of DNA and RNA; inhibits protein synthesis in the cancer cell

Absorption/Distribution: Well absorbed; crosses blood-brain barrier

Half life: 3–{endash}12 h

IV: 2–{endash}3 h

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: Varies by patient and indication

Elderly Dosage: Use caution

Child Dosage: Varies by patient and indication

Infant Dosage: Same as child dose

Dosage Forms: Oral solution compounding required; tablets: 25 mg and 50 mg; injection: in various strengths, lyophilized and nonlyophilized

By System: Hematopoietic

Warnings: Taken in morning to reduce risk of hemorrhagic cystitis

Frequent Side Effects: Gonadal suppression, leukopenia, darkening of skin and fingernails, nausea and vomiting, loss of hair

Occasional Side Effects: Anemia, thrombocytopenia, diarrhea, flushing of face, headache, increased sweating

Rare Side Effects: Hemorrhagic cystitis, hyperglycemia, hepatitis, stomatitis, long term risk of bladder cancer

Disease States: Bone marrow depression, chickenpox, gout, renal stones, hepatic and renal function impairment, infection

Other Drugs: Allopurinol, oral anticoagulants, blood dyscrasia–{endash}causing medications, bone marrow depressants, cocaine, other immunosuppressants, live virus vaccines

Lab Tests: Candida and mumps skin test, uric acid, tuberculin PPD skin tests

Administrative Notes: Frequently used in combination with other agents in various regimens; as a result, incidence and/or severity of side effects may be altered and possibly different dosages used

Cyclosporine

Trade Name(s): Sandimmune

Pregnancy Category: C

Medical Category: Immunosuppressant

Accepted Indications: Organ transplant rejection

Mechanism of Action: Inhibits production and release of interleukin-2

Absorption/Distribution: Incomplete from GI tract, variable

Half life: Biphasic, 10–{endash}27 h

PO: 3.5 h

Metabolism: Hepatic

Elimination: Biliary, fecal, renal

Adult Dosage: Capsules and solution, initial, 12–{endash}15 mg/kg/d beginning 4–{endash}12 h before surgery, continued for 1–{endash}2 w, then reduced; maintenance: 5–{endash}10 mg/kg/d, injection, IV infusion 2–{endash}6 mg/kg/d beginning 4–{endash}12 h before surgery and continued until patient can switch to oral solution

Elderly Dosage: Use with caution

Child Dosage: Same as adult dose

Dosage Forms: Capsules: 25 mg and 100 mg; oral solution: 100 mg/mL; concentrate for injection: 50 mg/mL

Frequent Side Effects: Gingival hyperplasia, hypertension, nephrotoxicity, hirsutism, tremor

Occasional Side Effects: Hepatotoxicity, infection, convulsions, acne, oily skin, headache, nausea, vomiting, leg cramps

Rare Side Effects: Hyperkalemia, pancreatitis, anaphylaxis, hemolytic-uremic syndrome, seizures

Contraindications: Chickenpox, herpes zoster, kidney and liver impairment

Antidotal Therapy: May include emesis

Disease States: Hyperkalemia, infection, malabsorption

Other Drugs: ACE inhibitors, heparin, beta blockers, androgens, cimetidine, danazol, diltiazem, erythromycin, estrogens, ketoconazole, miconazole, NSAIDs, hepatic enzyme inducers, hyperkalemia–{endash}causing medications, potassium–{endash}sparing diuretics, immunosuppressants, lovastatin, vaccines

Lab Tests: BUN, magnesium

Administrative Notes: Take exact amount of medication

Cyclothiazide

Trade Name(s): Generic only

Chemically Related To: Chlorothiazides

Pregnancy Category: C

Medical Category: Diuretic, antihypertensive, antidiuretic (diabetes insipidus), antiurolithic

Accepted Indications: Edema, hypertension, diabetes insipidus, renal calculi (prophylaxis)

Mechanism of Action: Inhibits sodium reabsorption in nephron

Absorption/Distribution: Rapid absorption

PO: 7–{endash}12 h

Elimination: Renal, bile

Research Notes: Onset of action 2–{endash}4 h; duration of action 18–{endash}24 h

Adult Dosage: 1–{endash}2 mg/d up to 6 mg

Elderly Dosage: May be more likely to have hypotension and electrolyte disturbances

Child Dosage: 20–{endash}40 m{mu}g/kg/d

Infant Dosage: Caution in infants with jaundice

Dosage Forms: Tablets: 2 mg

By System: Renal

Warnings: Avoid sun and sun lamps; do not take other medications

Precautions: Finish medication even if symptoms disappear

Frequent Side Effects: Electrolyte imbalance, hypokalemia

Occasional Side Effects: Anorexia, diarrhea, decreased sexual activity, photosensitivity, upset stomach

Rare Side Effects: Agranulocytosis, pancreatitis, gout, hepatic function impairment, thrombocytopenia, glucose intolerance

Antidotal Therapy: May include emesis or gastric lavage, monitor electrolyte concentration and kidney function

Disease States: Anuria, diabetes mellitus, gout, hyperuricemia, lupus erythematosus, pancreatitis, liver problems

Nutrition: Sodium restriction and weight reduction

Other Drugs: Lithium, neuromuscular blocking agents, sympathomimetics, digitalis glycosides, NSAIDs, dopamine

Lab Tests: Uric acid, urinary calcium, bilirubin, tyramine

Cyproheptadine Hydrochloride

Trade Name(s): Periactin

Chemically Related To: Piperidine antihistamines

Pregnancy Category: B

Medical Category: Antihistamine, appetite stimulant, vascular headache suppressant

Accepted Indications: Rhinitis, allergic conjunctivitis, pruritus, urticaria, angioedema, dermatographism, sneezing, rhinorrhea, loss of appetite, vascular headache

Unaccepted Indications: Cushing's disease, hypomotility

Mechanism of Action: Competitor for H1 receptor site

Absorption/Distribution: Well absorbed

Half life: 14–{endash}25 h

Peak activity: 6–{endash}9 h

Metabolism: Hepatic, renal

Elimination: Renal

Research Notes: Has an antiserotonin action

Adult Dosage: Initially 4 mg t.i.d. up to 500 m{mu}g/kg/d

Elderly Dosage: More chance of dizziness, sedation, or confusion

Child Dosage: 2–{endash}6 y: 2 mg every 8–{endash}12 h, not to exceed 12 mg/d; 6–{endash}14 y: 4 mg every 8–{endash}12 h, not to exceed 16 mg/d

Infant Dosage: Premature infants and neonates: not recommended

Dosage Forms: Syrup: 2 mg/5 mL; tablets: 4 mg

Warnings: May cause drowsiness; avoid alcohol

Precautions: Possible dry mouth; use sugarless gum or candy

Frequent Side Effects: Drowsiness, thick mucus

Occasional Side Effects: Blood dyscrasias, cardiac arrhythmias

Rare Side Effects: Blurred vision, dry mouth, increased appetite, GI problems, nightmares, urine retention

Contraindications: Liver problems

Overdosage: Anticholinergic effects, cardiac arrhythmias, drowsiness, hallucinations, convulsions, hypotension

Antidotal Therapy: No specific antidote; may include supportive treatment: emesis, gastric lavage, saline cathartics, vasopressors, or oxygen and IV fluids; do not use stimulants

Disease States: Other antihistamines, alcohol, CNS depressants

Administrative Notes: Appetite stimulant in children only

Cytarabine

Trade Name(s): Cytosar

Pregnancy Category: D

Medical Category: Antineoplastic

Accepted Indications: Leukemias, non-Hodgkin's lymphomas, Hodgkin's lymphomas, myelodysplastic syndrome

Mechanism of Action: Antimetabolite, immunosuppressant

Absorption/Distribution: Moderate amounts cross blood-brain barrier

Half life: Biphasic: 10–{endash}15 min and 1–{endash}3 h

Peak activity: 20–{endash}60 min (SQ)

Metabolism: Hepatic

Elimination: Renal

Adult Dosage: Maintenance dose: 1 mg/kg 1–{endash}2 times/w

Elderly Dosage: May require lower dose

Child Dosage: Same as adult dose

Infant Dosage: Safety and efficacy not established

Dosage Forms: Sterile injection: 100 mg, 500 mg, 1 g, and 2 g

Frequent Side Effects: Leukopenia, infection, stomatitis, thrombocytopenia, loss of appetite, nausea, vomiting

Occasional Side Effects: CNS toxicity, hyperuricemia, diarrhea, dizziness, headache, itching, freckling

Rare Side Effects: Thrombophlebitis, ARA-C syndrome (rash, bone and muscle pain, fever, weakness), GI hemorrhage, pulmonary edema, diffuse interstitial pneumonitis, urinary retention, hair loss, esophagitis, hepatotoxicity, megaloblastic anemia

Contraindications: Chickenpox, herpes zoster, infection

Disease States: Bone marrow depression, hepatic function impairment

Other Drugs: Probenecid, sulfinpyrazone, immunosuppressants, bone marrow suppressants, cyclophosphamide, live virus vaccines, methotrexate

Lab Tests: BUN, uric acid

0 comments: